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Abstract 
 
Neudesin, also known as neuron derived neurotrophic factor (NENF), is a non-canonical 
neurotrophic factor. Since it presents a heme/steroid binding domain in its structure, NENF is 
also a member of the membrane associated progesterone receptor (MAPR) family. In vitro 
studies have shown that recombinant NENF per se is able to induce proliferation and 
differentiation of embryonic cortical neurons and respective precursor cells. Of note, the addition 
of hemin to the media significantly increased the neurotrophic capacity of NENF in vitro, showing 
that heme successfully binds to NENF primary structure and indicating that heme is a prosthetic 
group needed for NENF activity, at least in vitro. Nevertheless, still much is unknown on the 
mechanism of action of NENF. Furthermore in vivo studies on NENF function are yet scarce. 
In this thesis, we have evaluated the importance of NENF for central nervous system (CNS) 
postnatal development and in adulthood, specifically at the behavioral, neurochemical and 
structural levels. Furthermore we characterized the adult neurogenic niches in the absence of 
NENF. For that, we have taken advantage of a unique mouse model with a target deletion of the 
entire neudesin gene, from now on designated as neudesin-null mice. We observed that in the 
absence of NENF, adult males have an anxious-like behavior, as it was assessed in the elevated 
plus maze (EPM), light/dark box (LDB) and novelty suppressed feeding (NSF) tests; surprisingly 
we have not seen the same anxious phenotype in the acoustic startle (AS) test. These results 
reveal a role for NENF in the regulation of state anxiety but not in generalized anxiety, at least in 
males. On the other hand, neudesin-null males do not show any motor, exploratory, depressive 
or cognitive alterations. This anxious phenotype was accompanied by impoverished dendritic 
arborization of ventral hippocampal granular cells as well as impaired dopaminergic activity, and 
shorter dendrites at the anterior medial division of the bed nucleus of the stria terminals 
(amBNST). These observations reveal a critical role for NENF in the maintenance of the anxiety 
circuitry, especially at the ventral hippocampus. Since neurodevelopment is highly regulated by 
neurotrophic factors, and might impact on adult behavior we have studied the postnatal 
acquisition of developmental milestones of neudesin-null animals during the first 21 days of 
postnatal life. We observed sex-differences regarding specific neurological reflexes dependent on 
the vestibular area maturation, with a mild delay on neurodevelopment observed only in 
neudesin-null males. This was followed by a neurochemical imbalance, evaluated in postnatal 
day 21, in body righting and position regulating brain regions. Specifically we observed that the 
brain stem of neudesin-null males showed increased serotonin and norepinephrine, a decreased 
 VIII 
serotonergic and dopaminergic activity in the cerebellum, diminished norepinephrine in the 
motor cortex and the vestibular area revealed less dopaminergic activity.  
Lastly we have characterized the proliferative capacity of neudesin-null mice neurogenic niches, 
in vivo and in vitro. We observed a sex difference in proliferation occurring in the sub granular 
zone (SGZ) of the dentate gyrus (DG) of the hippocampus. Neudesin-null male mice showed less 
labeling of BrdU cells than littermate controls, which was not observed in females. Assessing 
neurogenesis ratio by doublecortin (DCX) and BrdU positive cells, we have observed that 
neudesin-null males showed less neurogenesis only in the ventral division of the hippocampus. 
Furthermore, in vitro we observed that neurospheres formed by neural stem cells derived from 
the hippocampus of neudesin-null mice had an inferior clonal expansion capacity. All these 
evidences prompt us to propose that NENF might also have neurotrophic capacity in vivo, 
specifically at the ventral division of the hippocampus, but interestingly its importance is 
primordial in males. 
With this work we contributed to further unravel the biological role of NENF in the CNS.
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Resumo 
 
A neudesina, também designada por factor neurotrófico derivado de neurónios (NENF), é uma 
proteína com atividade neurotrófica. Esta tem na sua estrutura primária um domínio de ligação a 
grupos heme e esteroides que a classifica como um membro da família de proteínas dos 
receptores de progesterona associados à membrana (MAPR). Estudos in vitro demonstraram que 
a NENF per se é capaz de induzir proliferação e diferenciação de neurónios derivados do córtex 
embrionário e também das respetivas células precursoras desses neurónios. De salientar que a 
adição de hemina ao meio de cultura aumentou significativamente a capacidade neurotrófica da 
NENF, demonstrando que in vitro, a hemina se liga ao domínio da NENF e que atua como um 
grupo protético necessário para a atividade da NENF. No entanto, ainda muito pouco se sabe 
sobre o mecanismo de ação da NENF in vivo. 
Neste estudo, avaliamos a importância da NENF no desenvolvimento do sistema nervoso central 
(SNC) adulto e pós-natal, especificamente ao nível do comportamento, neuroquímica e estrutura. 
Adicionalmente caracterizamos os nichos neurogénicos adultos na ausência de NENF. Para tal, 
utilizamos um modelo animal de murganho sem o gene da neudesina, que daqui em diante 
designaremos de NENF-/-. Observamos que na ausência de NENF, os machos adultos têm um 
comportamento ansioso, observado em 3 diferentes testes que aferem os níveis de ansiedade 
contextualizada mas não num outro teste que afere a ansiedade generalizada. Isto sugere um 
papel para a NENF como modelador do comportamento ansioso contextualizado, o que envolve 
circuitos cerebrais específicos. Por outro lado, animais sem NENF não mostraram qualquer 
problema motor/exploratório, depressivo ou cognitivo. O fenótipo ansioso foi acompanhado por 
uma atrofia da arborização dos neurónios granulares do girus denteado do hipocampo ventral e 
também por uma desregulação da atividade dopaminérgica nesta região e assim como por 
dendrites mais curtas dos neurónios da divisão anterior medial do núcleo da estria terminal. 
Estas alterações revelam um papel crítico para a NENF na manutenção do circuito da ansiedade, 
especialmente no hipocampo ventral.  
Como o neurodesenvolvimento é regulado por fatores neurotróficos, estudamos a aquisição de 
marcos específicos do desenvolvimento pós-natal dos murganhos NENF-/- durante os primeiros 
21 dias de vida. Observamos uma diferença dependente do género em alguns reflexos 
neurológicos dependentes da maturação da área vestibular. Apenas os machos apresentam um 
atraso na aquisição destes reflexos. Este atraso foi acompanhado por uma desregulação 
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neuroquímica avaliada no dia pós-natal 21, em áreas do cérebro envolvidas em mecanismos de 
equilíbrio e posição do corpo. Especificamente, observamos um aumento de serotonina e 
norepinefrina no tronco cerebral de animais NENF-/-, assim como um aumento da atividade 
serotonérgica e dopaminérgica no cerebelo, diminuição de norepinefrina no córtex motor e uma 
diminuição da atividade dopaminérgica na área vestibular.  
Por fim, caracterizamos a capacidade proliferativa dos nichos neurogénicos de animais NENF-/-, 
in vivo e in vitro. Observamos uma diferença dependente do género na proliferação na zona sub 
granular do girus denteado do hipocampo. Os machos NENF-/- apresentam menos células BrdU 
positivas do que os controlos, o que não se observa nas fêmeas. Na avaliação da neurogénese 
pela contagem de neuroblastos em proliferação, observamos que os machos NENF-/- apresentam 
menos neurogenese a ocorrer apenas na divisão ventral do hipocampo. Adicionalmente, in vitro 
observamos que neuroesferas formadas a partir de células estaminais do hipocampo de animais 
NENF-/- apresentam uma capacidade clonal inferior. Este conjunto de evidências, leva-nos a 
propor que a NENF possui também capacidade neurotrofica in vivo, especificamente na divisão 
ventral do hipocampo  apenas em machos.  
Com este trabalho contribuímos para clarificar um pouco mais o papel da neudesina no sistema 
nervoso central. 
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1. Neudesin 
 
Neudesin, also known as neuron derived neurotrophic factor (NENF), spinal cord injury related 
protein 10 (SCIRP-10), cell immortalization-related protein 2 or secreted protein of unknown 
function, was firstly described in 2005 as a novel neuron secreted protein (Kimura et al., 2005). 
The multi designations for this gene are in part due to the fact that the neudesin gene was 
independently detected in a few genomic/transcriptome studies (Magdaleno et al., 
2006;Neubauer et al., 2006;Han et al., 2012;Byerly et al., 2013). It is of notice that, possibly 
given the relatively short time since the first description of the protein, scarce literature is 
available on the function and/or characterization of this protein. 
 
1.1 NENF gene and protein structure 
 
The neudesin mouse gene is a 11.41 kilobases (kb) sequence located in chromosome 1 with 4 
exons and 3 introns and a coding DNA sequence that ranges from nucleotides 27 to 542, which 
are 515 nucleotide long (figure 1). This sequence encodes for the mouse NENF protein that 
contains 171 aminoacids long. This amino acidic sequence is highly homologous between 
species but its N-terminal part differs between mammals and other classes of vertebrates. From 
the initial predictive analysis of the primary structure of the protein no similarities to any other 
secreted protein known at the time was found, and thus the protein was named neudesin (or 
neuron derived neurotrophic factor) and proposed as a novel secreted protein with neurotrophic 
activity over neurons but not astrocytes (Kimura et al., 2005), as will be described later in more 
detail. Further bioinformatic analysis by multiple sequence alignments on the protein structure 
revealed the existence in the mouse NENF protein of 3 amino acids residues that act as ligands 
for the iron-binding heme group (Kimura et al., 2008). In fact this work revealed the existence of 
a cytochrome-b5 like heme/steroid binding domain in the NENF protein (Kimura et al., 2008) 
which was the key element to classify NENF as a member of the membrane associated 
progesterone receptor family (MAPR). More recently, another secreted protein of the MAPR family 
was also identified, and named neuferricin (Kimura et al., 2010); this protein also has a 
cytochrome-b5 like heme/steroid binding domain, and similar to NENF, displays neurogenenic 
inducing activity. A putative role for MAPR family members in the development and function of 
the central nervous system (CNS) (Kimura et al., 2012) will be later discussed in this chapter. 
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Figure 1 – Neudesin gene schematization. Neudesin gene has 4 exons and 3 introns and there is no alternative 
splicing form known. 
 
Neudesin contains a heme/steroid-binding domain similar to the one of the cytochrome b5 
family, with clearly demonstrated heme-binding properties (Kimura et al., 2008). As indicated 
above this resulted in the classification of neudesin into the MAPR family, a subfamily of 
cytochrome b5 family, along with progesterone receptor membrane component 1 and 2 
(PGRMC1 and 2) and neuferricin. All these proteins share a homologous primary structure, 
especially at the cytochrome-b5 like domain and all depend on the binding of heme, as a 
prosthetic group, to its cytochrome b5 domain to exert their function. Although PGRMC1 and 
NENF share 40% of homology, at the heme-binding domain, they present different patterns of 
expression and cellular locations, being NENF a secreted protein and PGRMC1 is 
transmembranar (Rohe et al., 2009). 
 
1.2 NENF expression 
 
A complete characterization of the NENF ontogenic expression profile is not yet available. 
Embryonically, Nenf major expression sites are the brain, spinal cord, heart and lungs (Kimura et 
al., 2005). It is described that Nenf’s expression in the developing brain starts from E12.5 and 
was shown to be present up to E18.5. Specifically, Nenf was weakly detected at E12.5, clearly 
present at E13.5 and its expression levels increased until E18.5. At E13.5 it was observed that 
the pre-plate, where newly post-mitotic neurons are present, is the region where Nenf expression 
is higher, interestingly this region is constituted by neurons that migrated from the subventricular 
zone, where Nenf expression is lower (Kimura et al., 2006). Apparently, Nenf expression pattern 
in the developing mouse brain is coincident with the late maturation of neural precursors (E15.5) 
but starts prior to the appearance of mature neuronal marker the microtubule-associated protein 
2 (MAP-2) (Kimura et al., 2006). Similarly, its expression on early phases of cortical development 
seems restricted to post-mitotic neurons. Surprisingly, in vitro, neural precursor cells isolated at 
Unraveling the biological role of neudesin, a novel neurotrophic factor 	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E13.5 from the cerebral cortex, cultured for 48h in differentiating conditions, indicated that Nenf 
expression diminishes, inversely to the MAP-2 expression pattern (Kimura et al., 2006) (figure 2). 
This inconsistent pattern of expression between in vivo and in vitro conditions might suggest a 
paracrine control of Nenf expression by surrounding cells, that are not present in vitro; these cells 
are most probably post-mitotic and/or committed cells.  
 
 
Figure 2 – Schematic view of neudesin and different cellular markers expression in mouse embryonic cortex 
throughout development (in vivo) and in 48 h cultures (in vitro). 
 
It is of relevance that in the adult brain (P49) Nenf expression, evaluated by in situ hybridization, 
was found to be ubiquitous but restricted to neurons (Kimura et al., 2005). Nevertheless, Nenf 
expression pattern was not homogeneous; the hippocampus, cortex, thalamus and hypothalamus 
were the regions where Nenf expression was detected to be the highest. It should be noted that 
in adulthood (P49), detectable levels of Nenf mRNA were also present in other organs/systems 
other than the nervous system, such as the heart, lung, kidney, and in the white adipose tissue 
(WAT) (table 1) (Kimura et al., 2005). In case of pathology, particularly breast carcinoma, there is 
a report that showed NENF to be up regulated in estrogen receptor+/progesterone receptor+ 
tumors but not in estrogen receptor+/progesterone receptor- tumors (Neubauer et al., 2006). This 
observation suggests that NENF might play a role in other organ/systems besides the nervous 
system, which is similar to what is described for classical neurotrophins. 
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MAP2 
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NENF 
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time 
point 
brain heart lung WAT 
smooth 
muscle 
testis stomach 
PND49 ++ +++ ++ ++ + + + 
        
E18.5 +++ ++ - ? + ? - 
 
1.3 NENF function 
 
When NENF was initially described a body of evidence for its function as a "putative neurotrophic 
factor” was found (Kimura et al., 2005). As indicated previously, posterior analysis of its primary 
structure revealed the presence of a heme/steroid binding domain, which resulted in the 
classification of NENF as a member of the MAPR family, and prompted for other potential 
functions of neudesin. Given this, we will next independently approach each function of NENF.  
 
1.3.1 Neudesin role as a neurotrophic factor 
 
Evidence for a potential role of neudesin as a neurotrophic factor was born from in vitro studies 
that showed that recombinant NENF protein enhances proliferation and survival of E18.5 
cerebral cortex neuronal cultures in a dose dependent manner. This was partially similar to what 
was described for the effect of fibroblast growth factor-2 (FGF-2), since neudesin only displayed 
neurotrophic activity in neuronal cultures but not in astrocytic cell cultures (Kimura et al., 2005). 
Proliferation and survival mechanisms in vitro are associated to the activation of the Mitogen-
activated protein kinases (MAP) and phosphatidylinositide 3-kinases (PI3-K) pathways. FGF-2 and 
neurotrophins in general activate these pathways similarly to what was observed for NENF. The 
effect of NENF in these signaling pathways was further demonstrated since its activity was 
abolished when specifically ERK1/2 and Akt inhibitors were used in the same conditions (Kimura 
et al., 2005). In order to explore a possible receptor upstream of the phosphorylation of ERK1/2 
and Akt, inhibition of tyrosine kinase receptors for FGF, EGF and IGF-I was tested, however when 
stimulated with recombinant NENF phosphorylation of ERK1/2 and Akt still occurred. This 
suggests that NENF’s activity does not cross with the activation of other neurotrophic factors 
receptors. Interestingly, Gi/Go-protein inhibitor pertussis toxin (PTX) was able to disrupt ERK1/2 
Table1 – Expression profile of NENF in adult and embryonic mice. 
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and Akt phosphorylation as well as recombinant NENF’s neurotrophic effect (Kimura et al., 
2005). This indicated that, at least in neurons, the most probable receptor candidate for NENF is 
a Gi/Go-protein-coupled receptor (Kimura et al., 2005). In addition to these neurotrophic 
function, recombinant NENF was also able to decrease terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL) positive cells in primary cultures of cortical neurons, showing 
also a neuroprotective effect (Kimura et al., 2005), but the mechanism involved in this process is 
still not understood. 
On the other hand, NENF might modulate early stages of neural development, namely by 
stimulating neurogenesis and promoting the differentiation of neurons in E13.5 precursors cell 
cultures (Kimura et al., 2006). MAPK, PI3-K and protein kinase A (PKA) pathways mediate these 
actions but, contrary to what was demonstrated in E18.5 isolated cells, this activation was not 
promoted by the Gi/Go-protein-coupled receptor. Indeed, even in the presence of FGF-2, 
recombinant NENF is able to potentiate the differentiation of neural precursors into MAP-2 
positive neurons, specifically by PI3-K and PKA pathways (Kimura et al., 2006). On the other 
hand, the proliferation of E13.5 isolated cortical neural precursor cells in vitro was not observed 
in the presence of recombinant NENF for longer than 48h, but a similar proliferative effect to the 
one induced by FGF-2 was observed in the first 24 h in culture (Kimura et al., 2006). Of notice, 
MAPK and PKA pathways, but not the PI3-K pathway, mediated this transient induction of cell 
proliferation by the action of recombinant NENF (figure 3).  
Another interesting finding related to NENF action was the fact that recombinant NENF, in the 
presence of fetal bovine serum (FBS), inhibits the differentiation of astrocytes (Kimura et al., 
2006). This suggests that NENF’s role in neurogenesis is dual: it maintains the stemness 
capacity of uncommitted neural stem cells and also, once they enter a differentiated state, NENF 
is able to potentiate differentiation into a neuronal but not astrocytic phenotype, at least in vitro.  
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Figure 3 - Schematic representation of neudesin activation pathways in vitro. 
 
Evidence exists with cell types other than neural cells demonstrating the proliferative inducing 
capacity of NENF. For instance, the same properties were observed with experiments in a mouse 
neuroblastoma cell line (Neuro2a). Specifically, Nenf siRNA knock down was able to disrupt the 
phosphorylation of ERK1/2 and Akt of this cell line (Kimura et al., 2008). Another study showed 
a evidence contributing for the signaling activation pattern of NENF, the cDNA transcript of Nenf, 
at the time denominated as CIR2, was described to be over expressed in immortalized cells (Ma 
et al., 1998), specifically in the human SV-40 transformed human embryonic kidney (HEK) cell 
line. But further functional analysis on the relevance of CIR2 (or NENF) in the immortalization 
and proliferation inducing process was not pursued. NENF has also been described to participate 
in the maintenance of the proliferative status of adipose precursor cells. Namely, recombinant 
NENF, in vitro, inhibits adipogenesis of an adipocyte-like cell line derived from 3T3 classic 
fibroblast cell line, the 3T3-L1 cell line. This inhibition occurs by preventing adipocytes precursors 
to differentiate into mature adipocytes. The signaling cascade by which this continuous 
proliferative state occurs is via phosphorylation of ERK1/2 or MAPK activation, but not Akt 
phosphorylation. This maintains the stemness properties of adipocyte precursors (Kimura et al., 
2009).  
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As described above the activation pattern involved in the mechanism of action of NENF occurs, 
although not simultaneously, through MAP and PI3 kinase and AKT pathways. This is similar to 
the activation patterns of neurotrophins and other neurotrophic factors. Ultimately this activation 
results in the survival, proliferation and/or differentiation of both mature and precursors cells. 
These evidences favored the classification of NENF as a neurotrophic factor. Nevertheless, it is 
not known through what receptor, or any other partner proteins, these properties are elicited by 
NENF. On the other hand and given that these actions of NENF were demonstrated in vitro, it is 
not clear if NENF induces the same effects in vivo. 
 
1.3.2 Neudesin role as a heme-binding protein 
 
Heme acts as a prosthetic group of several heme-binding proteins such as cytochromes, 
hemoglobin, myoglobin and others. Importantly, NENF was the first extracellular protein, with 
heme-binding activity, to be described to activate intrinsic signal transduction. As described 
previously (section 1.1) it was shown that mouse NENF presents 3 residues that act as ligands 
for the iron-binding heme group (Kimura et al., 2008). Moreover in vitro studies using the 
Neuro2a cell line have shown that, in fact, recombinant NENF requires hemin binding to its 
primary structure to exert survival and anti-apoptotic actions. Contrarily from what was seen in 
primary brain cultures, proliferation of Neuro2a was enhanced in the presence of recombinant 
NENF but this effect was significantly boosted when free hemin was added to the culture 
medium. Of notice, hemin per se was not able to promote any of these actions (Kimura et al., 
2008).  
Interestingly not only recombinant NENF potentiated proliferation and survival of Neuro2a cells 
but also, when endogenous Nenf was knocked-down by siRNA, proliferation and survival of cells 
was halted, thus eliminating the possible artifact of external addition of NENF to cell media. 
Moreover it was shown that this cell line secretes NENF into the media. Endogenous NENF was 
then quantified for its binding capacity to heme using a heme-affinity chromatography, which 
revealed that all endogenous NENF was bound to hemin (Kimura et al., 2008).  
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1.3.3 Neudesin role as a steroid-binding protein 
 
While NENF displays a steroid-binding domain, NENF binding to steroids was not detected 
(Kimura et al., 2008). It should be noted that the later experiments were performed by dot blot 
analysis of recombinant NENF incubation with different steroids, and this methodology might not 
be the most appropriate if NENF binding to any steroid occurs with low affinity. Nevertheless the 
in vivo interaction of NENF with steroids is still a matter of dispute, especially since NENF 
primary structure holds 30% of homology to membrane associated progesterone receptor 
component 1 (PMGRC1) (Cahill, 2007;Kimura et al., 2012), which activates P450 proteins, that 
are involved in drug, hormone and lipid metabolism (Losel et al., 2008). Similarly to NENF, in the 
case of PGRMC1 the binding of progesterone still suffers from conflicting evidence, with some 
authors demonstrating direct binding (Meyer et al., 1996;Peluso et al., 2008;Peluso et al., 2009) 
and others arguing in favor of PGRMC1 not bind directly to progesterone but instead forming a 
complex with proteins that together bind progesterone (Rohe et al., 2009). The same holds true 
for other steroids such as, corticosterone, testosterone and cortisol and drugs (Meyer et al., 
1996;Min et al., 2005;Rohe et al., 2009). Progesterone binding to PGRMC1 complex was shown 
to promote proliferation and cell cycle gene expression of neural precursor cells through 
PGRMC1 and 2 by activation of MAP kinase pathways, similarly to the activation induced by 
NENF (Liu et al., 2009). The possibility of NENF forming a complex with other proteins and then 
binding progesterone has not been demonstrated yet. But indeed it has been shown that NENF 
signiling pathway activation is blocked by inhibition of Gi/Go-protein-coupled receptor. And in 
fact, another group of membrane proteins known to bind to progesterone (mPR) that belong to 
the progestin and adipoQ receptor (PAQR) family, are thought to be unique G protein-coupled 
receptors that act through cAMP (Thomas and Pang, 2012). 
The general mechanism of action of progesterone occurs via genomic regulation; for this 
progesterone enters the cells and binds nuclear receptors that in turn modulate gene 
transcription. On the other hand progesterone also induces non-genomic actions. Given the 
lipophilic nature of progesterone, Kimura and colleagues (2013) have hypothesized that NENF 
might be important to retain progesterone from entering the cell. In this way and by forming a 
complex (NENF-progesterone), NENF would be able to induce the non-genomic actions of 
progesterone via activation of membrane receptors (figure 4). The need of NENF as a stabilizer of 
progesterone at the cellular membrane or a complex formation in order for non-genomic 
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signaling activation of progesterone to occur is nevertheless still an elegant hypothesis (Kimura et 
al., 2013). Despite the speculative nature of this mechanism of NENF action, it is of note that 
recently a non-genomic signaling activation induced by progesterone binding to membrane 
receptors (PGRMC1 and mPR) has been demonstrated (Singh et al., 2013). 
 
Figure 4 - Schematic representation of the hypothesis of neudesin and progesterone interaction. 
 
1.3.4 Other roles of neudesin 
 
Despite the in vitro evidence, NENF physiological role is still largely unknown. Very recently the 
first report showing an in vivo function for NENF was published. NENF was observed to be highly 
expressed in some nucleus of the hypothalamus involved in feeding behavior regulation, as the 
arcuate nucleus (Arc) and the paraventricular nucleus (PVN). Furthermore, it was shown that 
interacerebroventricular delivery of recombinant NENF to the brain had and anorexigenic like 
effect, diminishing animals appetite and body weight by the activation of melanocortin signaling 
(Byerly et al., 2013). The NENF function shown in this work has a neurotrophic support but in a 
more selective form, namely by modulating specific neuronal populations (proopiomelanocortin+ 
(POMC) neurons), as well as, the BDNF receptor expression, tyrosine kinase B (trkB). The 
modulatory actions of NENF shown in this work were very similar to the ones observed by BDNF 
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in the same conditions (Byerly et al., 2013), which adds in favor of the potential of NENF as a 
neurotrophic factor in vivo. This study was the first to bring insight for NENF neurotrophic 
modulation of physiologic states such as anorexia and orexigenia (Byerly et al., 2013). 
 
Given the singular nature of NENF, the rather minute reference to it in the literature and the 
many gaps still existing in what concerns NENF action, we will next give further background and 
insight into the general functions of other molecular players that display properties similar to the 
ones of NENF. 
 
2. Neurotrophic factors 
 
 Classically, neurotrophic factors can be defined as molecules (peptides or proteins) 
essential for the differentiation, maturation or survival of specific populations of neurons from 
embryonic to adult life (Henderson, 1996). There are 3 major families of classical neurotrophic 
factors. The neurotrophins family which includes nerve growth factor (NGF), brain-derived 
neurotrophic factor (BDNF), neurotrophin 3 (NT3) and 4/5 (NT-4/5); the neurokines, including 
ciliary neurotrophic factor (CNTF) and leukaemia inhibitory factor (LIF); and, the transforming and 
fibroblast growth factor families, which includes TGF-β1, TGF-β2, TGF-β3, FGF family members 
and their distant relative glial cell line derived neurotrophic factor (GDNF) (Segal and Greenberg, 
1996). 
 
2.1 Role of neurotrophic factors in brain development 
 
The “neurothrophic hypothesis” postulates that a neurotrophic factor might be essential for the 
correct development of a certain population of neurons and that it exists in less quantity than the 
necessary for the maintenance of the entire neuronal population (Davies, 1996). In this sense, 
knockout (KO) models for neurotrophic factors and their receptors have been an exceptional tool 
to study neurotrophic action mainly during nervous system development (Snider, 1994).  
The levels of neurotrophins and its receptors are generally high throughout the mammalian CNS 
development. Being expressed in different stages in various structures of the nervous system, 
since the neuroepithilium and neural tube stage until adult brain structures, as hippocampus, 
striatum and basal ganglia (Bartkowska et al., 2010). During embryonic development, 
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sympathetic and sensory ganglia neurons are the most vulnerable structures to neurotrophic 
fluctuations, with the absence of neurotrophic support resulting in severe cell loss (Levi-
Montalcini, 1987;Purves et al., 1988). In the CNS, the absence of neurotrophins results in a 
milder phenotype, with a bland neuronal loss, suggesting that neurotrophins, per se, do not play 
a crucial role in the survival and differentiation of CNS neurons at least during embryonic 
development. Instead the absence of certain or combined neurotrophins and/or their receptors 
result in abnormal neuronal phenotypes. For example, BDNF KO mice present increased death of 
cerebellar granule cells, resulting in abnormal cerebellar patterning and foliation (Schwartz et al., 
1997). In the same line, absence of trkB or trkC neurotrophin receptors induces cell loss, 
specially in the dentate gyrus, during the first postnatal weeks and this phenotype is worse in 
double KO trkB /trkC (Minichiello and Klein, 1996). NGF or trkA KO mice do not show cell loss in 
the CNS throughout the fourth postnatal week, instead they shown an abnormal cholinergic 
system, resulting in specifically loss of cholinergic neurons in the striatum and septal region of 
young adults trkA KO mice (Fagan et al., 1997). 
Knockout mouse models for single neurotrophins, combination of 2 or knockout of the 
combination of a neurotrophin and their receptor, show a poor viability with developmental 
abnormalities (Agerman et al., 2003) where the vestibular and the cochlear nucleus, along with 
the nodose-petrosal and dorsal root glangia are main structures suffering cell lose (reviewed at 
(Huang and Reichardt, 2001).  
It should be noted that most neurotrophins and their respective receptors, with the exceptions of 
NT3/4 and p75, are essential for postnatal life, since homozygous mutant mice die prenatally or 
within the initial postnatal weeks (Bartkowska et al., 2010). The severity of the phenotypes 
observed suggests that a variety of organ systems fail due to the lack of neurotrophin signaling, 
and not all entirely related to neuronal abnormalities (Bartkowska et al., 2010). Another potent 
neurotrophic factor, FGF2, is known to be highly expressed in embryonic and postnatal 
ventricular zones as well as in neural stem cells. Indeed KO for FGF2 show an abnormal cortical 
and hippocampal development (Raballo et al., 2000) and importantly this has consequences in 
adulthood. 
All of these cellular modulatory actions are essential for the correct neuro development and 
ultimately have consequences in adulthood. For instance, vestibular neurons require BDNF and 
NT3 for survival while nodose-petrosal ganglion complex sensory neurons require BDNF and 
NT4/5 (Ernfors et al., 1995). A conditional depletion of BDNF solely in the embryonic brain 
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results in a pronounced effect in adulthood, namely depressive-like behavior and deficits in 
serotonin A2 receptor, which underlines the importance of this neurotrophin during development 
(Chan et al., 2006). 
 
2.2 Role of neurotrophic factors in brain function and behavior 
 
Neurotrophins are important modulators of adult CNS. Several lines of evidence have shown that 
neurotrophins play a major role in the modulation of synaptic transmission, long-term 
potentiation and depression, neuronal excitability, structural synaptic plasticity, axonal and 
dendritic branching, synapse number, size, and maturity (reviewed in (McAllister et al., 
1999;Hagg, 2009).  
Neurotrophins expression throughout the adult CNS supports the understanding of their crucial 
role in the adult brain. Although BDNF, NT3 and NT4/5 and the receptors TrkB and C are widely 
expressed throughout the adult brain, NGF is restricted to striatal and basal forebrain cholinergic 
neurons (Bartkowska et al., 2010). On the other hand BDNF, NT3, NT4/5, TrkB and C 
expression increases in abundance postnatally, peaking at P14 (in the rat) (Ringstedt et al., 
1993;Knusel et al., 1994), which, in fact, correlates with maximal neuronal growth, 
differentiation, and synaptogenesis processes in the brain. 
Of all the neurotrophic factors referred above, BDNF is the most studied in both short-term and 
long-term neurotrophic cellular modulation in the adult brain. In adulthood, BDNF is mostly 
expressed throughout the entire hippocampus, amygdala, pre-frontal cortex (PFC) and 
hypothalamus (Broad et al., 2002). The strong expression of BDNF in the hippocampus and its 
increased presence at the synapse upon glutamatergic stimulus, points to a particular role for 
BDNF in hippocampal glutamate projections modulation (Hartmann et al., 2001). Indeed, during 
chronic stress exposure there is a reduction of BDNF expression [as well as NGF and NT3 
(Ueyama et al., 1997)] at important stress response regions that recovers to normal levels upon 
effective treatment. (Mallei et al., 2002;Khawaja et al., 2004). Furthermore, these alterations are 
associated with the pathological hallmarks of stress such as neuronal death, dendrite atrophy 
and synaptic loss (Hill et al., 2012). While a link between BDNF, glutamatergic 
neurotransmission and depression has been established, a similar relationship between BDNF, 
GABAergic neurons and other psychiatric disorders, such as anxiety (GABAergic alterations) has 
not been demonstrated. In fact, GABAergic neurons express BDNF at very low levels (Brunig et 
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al., 2001). Whether other neurotrophic factors might play a more predominant role in this case is 
unknown. It would certainty be interesting to explore a role for NENF action in the modulation of 
these circuits/behavior.  
BDNF was also shown to be involved in depression and anxiety modulation since epidemiologic 
studies have shown that humans that carry the BDNF Val66Met polymorphism have reduced 
serum levels of BDNF, as well as 11% hippocampal atrophy (Egan et al., 2003;Bueller et al., 
2006). This was also seen in knock in BDNF Val66Met homozygous mice, which showed to have 
reduced levels of BDNF, hippocampal atrophy and a depressive and anxious like behaviors (Chen 
et al., 2006).  
Other neurotrophic factors, besides BDNF, also play a relevant role in affective and anxiety 
related disorders. Indeed FGF family proteins have been shown to modulate behaviors of anxiety, 
depression, or substance abuse (Turner et al., 2012). For instance, FGF2 was associated to the 
modulation of affective disorders, such as anxiety; specifically ablation of FGF2 in the 
hippocampus (using lentivirus) display an anxious-like behavior (Salmaso and Vaccarino, 2011). 
NGF is another neurotrophin whose expression is altered in particular brain regions under certain 
conditions. For instance, in bipolar disorder, lithium treatment increases NGF in hippocampus 
and other brain regions (Hellweg et al., 2002). Indeed, in a rodent model of chronic i.c.v. delivery 
of NGF results in enhanced recognition memory and neurogenesis (Birch and Kelly, 2013). In 
fact, neurotrophic factors such as CNTF participate in the cellular mechanisms involved in anxiety 
and depression, as CNTK KO adult mice show to have loss of GABA neurons and impaired 
serotonergic activity, which results in an anxious and depressive like behaviors (Peruga et al., 
2012).  
 
Undeniably, neurotrophic factors are well known regulators of the adult neurogenic niches as one 
of their important functions is the maintenance of the stemness capacity and correct 
differentiation of the niches. Adult neurogenesis at the hippocampus takes place at the sub 
granular zone (SGZ) through out all dorsal/ventral axis of the dentate gyrus (DG) and the adult 
subventricular zone (aSVZ) lining the lateral ventricles of the adult brain.  
Neurogenesis occurring, specifically at the DG has a functional output in the adult brain, 
specifically in psychiatric disorders such as mood disorders (Duman and Monteggia, 2006). It is 
well described that the successful treatment of mood disorders with anti-depressants, specially 
fluoxetine has its major out comes after 3 to 4 weeks, which can be correlated with the time 
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needed for new neurons to rise on the DG, accompanied by a significant increase of BDNF 
expression. Interestingly, chronic treatment (28 days) with anti-depressant can increase 
neurogenesis in the SGZ (Santarelli et al., 2003). On the other hand, it is observed a correlatable 
trend of decrease in hippocampal neurogenesis with stress related episodes associated with 
depressive like behavior and with a decrease expression of BDNF and NT-3 in stress regulatory 
related regions (Duman and Monteggia, 2006). Other neurotrophic factors have been shown to 
increase adult neurogenesis, as IGF-I (Aberg et al., 2000), associated with effective anti 
depressant treatment (Hoshaw et al., 2005). Vascular endothelial growth factor (VEGF) also 
fluctuates with anti-depressive treatment and regulates the rate of neurogenesis (Fabel K et al., 
2003). It is also known that absence of specific neurotrophic factors during development, such 
as FGF2 lead to deficits in hippocampal neurogenesis that cannot be reverted (Werner et al., 
2011). But there is also reports showing that neurotrophic factors negatively control 
neurogenesis; for instance, TGF1 is found to be up regulated in aging and that its over expressing 
in the brain blocks adult neurogenesis (Buckwalter et al., 2006) and that chronic delivery of 
GDNF induces the formation of new neural cells even when delivered to non neurogenic niches, 
such as the substancia nigra (Chen et al., 2005). Importantly, physical exercise and enriched 
environment are known to be potent inducers of hippocampal neurogenesis and this modulation 
is known to also over express BDNF or NGF (Jha et al., 2011;Birch et al., 2013). Considering all 
these findings, it is known that the adult neurogenic niches are under high regulation of 
neurotrophic factors and that their expression fluctuation has functional implication, namely in 
the hippocampal DG.  
 
  3. Heme/steroid binding proteins 
 
There is a family of proteins that share common structural evidence: the presence of a heme and 
steroid binding domain in the primary protein structure. These proteins generally depend on the 
binding of heme to their cytochrome-b5 domain as a prosthetic group for full activity and function 
(Lederer, 1994). Hemoglobin, cytochromes, and guanylate cyclases, all belong to this family, 
although they do not share much functional properties between them. The major heme-binding 
proteins in mammals are hemoglobin and myoglobin, which need heme for oxygen transportation 
(Reedy et al., 2008). Heme-binding proteins participate in several different functions, such as 
Unraveling the biological role of neudesin, a novel neurotrophic factor 	  
 17 
oxygen transportation, catalytic activity, electron transfer, and signaling functions as well as 
microRNA processing.  
Regarding steroids, they are a class of organic compounds that contain 4 alkanes with methyl 
groups. Classical types of steroids are cholesterol, sex hormones (estrogen, progesterone, 
testosterone) and the stress hormone cortisol (corticosterone in rodents). They are classically 
involved in neuroendocrine regulation but also in non-classical functions, especially in the brain. 
Here we will focus on the role of sex steroids, particularly progesterone, in the brain.  
 
  3.1 Steroids in brain development 
 
Physiologically the rise of different sex steroid/hormonal systems appears during postnatal 
development (Gore, 2008). This requires the development and maturation of a steroid-sensitive 
network between the reproductive organs and the brain hypothalamus during critical 
developmental windows. In fact, the mammalian brain is quite sensitive to sex hormone during 
late embryonic and early postnatal periods. Importantly, the mother’s estrogens do not intervene 
in the masculinization of the brain due to alpha-fetoprotein (De Mees et al., 2006).  
The developing brain exposure to sex hormones has a crucial influence in the sexual dimorphism 
of brain development and this process is closely regulated resulting in dimorphic development of 
brain regions that later in adulthood will result in female and male behaviors (Simerly, 1989). As 
an example, the anteroventral periventricular nucleus is bigger in females than males, and it is 
known that postnatal stress results in an increase of this nucleus in males, rising in a 
feminization of the brain (Sumida et al., 1993). Nuclear sex hormones receptors as estrogen 
receptors (ERα, ERβ), androgen receptors (AR) and progesterone receptors (PR) are expressed in 
the brain throughout development and participate in the epigenetical changes inherent to the 
dimorphic development of males and females (Tsai and O'Malley, 1994). In fact 
neuroendocrinology studies were among the first to reveal that embryonic and postnatal 
environment play a key role in determining adult physiology and behavior in mammals (Gore, 
2008). Although the gonads only begin to produce large amounts of sex hormones in puberty, 
the brain dimorphic differentiation occurring early in life is fundamental for current reproductive 
capacity (Gore, 2008). Meanwhile, puberty is another time window of development in which the 
brain is sensitive to the organizational effects of steroid hormones. This period is characterized by 
neurite and dendritic growth and synaptogenesis of hormonal sensitive brain regions such as the 
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hypothalamus (Matsumoto and Arai, 1977;Arai and Matsumoto, 1978). As ascribed, steroids 
have a particular important role in the development of the brain. The classic PR is shown to be 
transiently expressed in the embryonic and postnatal periods, especially at the hippocampus and 
caudate putamen, suggesting an exclusive developmental function for progesterone (Wagner, 
2008).  
 Unquestionably, all mechanisms involving the steroid system regulation during theses critical 
developmental periods will have somber influence in the correct orchestration of the entire brain 
gonadal network.  
 
  3.2 Steroids in adult brain 
 
Finger imprinting, epigenetical changes and neuro-endocrine regulation by sex hormones in the 
brain are of extreme importance for the correct reproduction and survival of the species. But 
recently additional modulatory functions have arised, other than reproductive related, provided by 
sex hormones, in particular estrogen and progesterone, which involve non-genomic regulatory 
actions such as, neurogenesis, neuroprotection, mood alteration, oxidative metabolism and 
cancer progression (McEwen, 1991).  
Here we will focus on the modulatory function of progesterone in these non-reproductive 
functions, specifically in the brain. In adulthood, the ovaries in females and the testis and adrenal 
cortex in males produce the majority of progesterone (Strauss and Barbieri, 2009). Surprisingly, 
the levels of progesterone in males and females are identical, but surprisingly males seem to 
have much higher expression of PR than females in the brain (Wagner, 2008).  
Although the involvement of progesterone in these function is in a non-classical way, involving 
other membrane proteins, such as, membrane progesterone receptor-alpha (mPRα, mPRβ, 
mPRγ), progesterone receptor membrane component-1 (PGRMC1), PGRMC2 and maybe NENF 
that are known to activate downstream cytoplasmic kinase signaling thus resulting in both 
transcription-independent and transcription dependent effects. One of the potential functions of 
the MAPR family members (PGRMC1 and 2) is the regulation of non-genomic actions of 
progesterone. MAPR members are known to activate cell viability mechanisms involving cellular 
cascades, but the upstream mechanism by which these cascades are activated is still not totally 
clear with progesterone being a strong candidate. Among the several non-genomic cellular 
cascades that progesterone activates are the MAPK, cAMP/protein kinase A (PKA) and PI3 K/Akt 
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pathways (Simoncini and Genazzani, 2003). 
In fact, the classical progesterone receptors activation also has been shown to be 
neuroprotective, namely by activating the transcription of BDNF. Surprisingly knockout mice for 
the classical nuclear PR also showed progesterone activity dependence (Krebs et al., 2000) that 
is membrane PR dependent but not nuclear PR dependent. This study revealed that although it is 
not yet known how progesterone exerts non-genomic function, they are as much important as the 
classic ones. One strong possible way by which the neuroprotective effects might be modulated 
is the activation of neurotrophic factors expression. Progesterone can induce BDNF expression 
not only by the nuclear PR but also through PGRMC1 (Su et al., 2012).  
Two membrane receptors able to interact with progesterone have been identified, membrane 
progesterone receptors (mPRs) and the progesterone membrane receptor component (PGMRC). 
The mPR has a high affinity for progesterone binding and although nuclear PR and mPR are 
expressed in the same brain regions, such has hippocampus, cortex, hypothalamus, and 
cerebellum, they have different cellular expression patterns; mPR are preferentially expressed by 
neurons and not glia in basal conditions. But wide cellular expression of mPR is known to occur 
in traumatic brain injury, showing an anti-inflammatory role in the brain (Meffre et al., 2013). On 
the other hand, PGRMC (1 and 2) binding to progesterone is still a matter of debate; most 
probable PGRMC1 participate in the formation of a membrane complex, with affinity to bind 
progesterone and other steroids and same drugs as well (Thomas, 2008). Both of these 
membrane receptors are expressed in the brain and studies revealed that the two independently 
have been associated to progesterone non-genomic function, such as in progesterone-increased 
neural progenitor proliferation or decreased starvation-induced apoptosis in hippocampal 
neuronal cells (Liu et al., 2009;Pang et al., 2013). Indeed progesterone’s non-genomic actions 
have been implicated in the regulation of the adult hippocampal neurogenesis since progesterone 
increases neural progenitor cells cell cycle in vitro (Liu et al., 2009) and in vivo it was seen that 
progesterone intra peritoneal delivery promoted survival of new born neurons in the SGZ, while 
the inhibition of 5alpha-reductase by finasteride did not affect this progesterone action, indicating 
that the progesterone effect is exerted by itself and not its metabolites (Zhang et al., 2010). 
The first observation that a faster and non-genomic mechanism of action for progesterone existed 
was seen by its rapid anesthetic effects (Selye and Masson, 1942) and in fact progesterone has 
modulatory effects in neurotransmitter systems, specially the GABAergic. In vivo progesterone 
actions can also occur by its metabolization into neuro active neurosteorids. In fact, the most 
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studied neurosteroid is allopregnalone or 3α, 5α tetrahydroprogesterone, synthesized from 
progesterone by the 5α-recuctase enzyme. Nevertheless, neurosteroids are well-known 
modulators of anxiety by allosteric modulation of GABAAR, mediating chloride influx, and indeed 
there has been observed a significant increase of neurosteroids in patients with generalized 
anxiety disorder (Semeniuk et al., 2001). It is believed that this increase might be a coping 
mechanism for a negative feedback (Strohle et al., 2003). Although neurosteroids were observed 
to interact with different receptors besides GABAAR, like 5-HT3 receptors, oxytocin receptors, N-
methyl-d-aspartate (NMDA) or sigma1 receptors, the exact output of these interaction is not 
understood (Meyer et al., 2002). It is also known that stress elevates the levels of specific 
neurosteroids and this way a possible modulation of the depressive behavior has been 
hypothesized, saying that the long lasting effect shown by selective serotonin reuptake inhibiters 
(SSRI) treatment would not be through elevation of serotonin but instead by stimulation of the 
allopreganalone catalytic enzymes 5α-reductase and 3 α-hydroxysteroid oxidoreductase (Serra et 
al., 2001). All these evidences make the role of neurosteroids an extremely exciting opportunity 
for understanding the modulation of brain physiology. But specifically, allopregnalone has also 
been found to participate in the protecting effect mediated of progesterone by participating in the 
inhibition of apoptosis during brain injury (Sayeed et al., 2009), as well as, to have potential 
effects on neurogenesis (Wang et al., 2008) and participate in the regulation of BDNF (Nin et al., 
2011).  
These evidences show the potential role for steroids, particularly progesterone, in adult brain 
physiology and function. 
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2. Aims and goals 
 
The goal of this work is to understand the role of neudesin (NENF) in the central nervous system 
(CNS). For that we have taken advantage of a unique mouse model with a deletion of the 
neudesin gene, neudesin-null mice, to study the impact of NENF in vivo, particularly in the brain.  
 
Specifically we aim at: 
 
I) Understand the impact of NENF ablation in CNS functioning, namely in adult 
behavior, neurotransmission and brain morphology. 
 
II) Characterize the postnatal neurological developmental of neudesin-null mice.  
 
III) Unravel whether NENF plays a role as neurotrophic factor in vivo, namely in the 
adult neurogenic niches. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Neudesin is involved in anxiety behavior: structural and neurochemical 
correlates
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Neudesin (also known as neuron derived neurotrophic factor, Nenf) is a scarcely studied
putative non-canonical neurotrophic factor. In order to understand its function in the
brain, we performed an extensive behavioral characterization (motor, emotional, and
cognitive dimensions) of neudesin-null mice. The absence of neudesin leads to an anxious-
like behavior as assessed in the elevated plus maze (EPM), light/dark box (LDB) and
novelty suppressed feeding (NSF) tests, but not in the acoustic startle (AS) test. This
anxious phenotype is associated with reduced dopaminergic input and impoverished
dendritic arborizations in the dentate gyrus granule neurons of the ventral hippocampus.
Interestingly, shorter dendrites are also observed in the bed nucleus of the stria terminalis
(BNST) of neudesin-null mice. These findings lead us to suggest that neudesin is a novel
relevant player in the maintenance of the anxiety circuitry.
Keywords: neudesin, anxiety, dopamine, ventral hippocampus, bed nucleus of the stria terminalis
INTRODUCTION
Neudesin (also known as neuron derived neurotrophic factor,
Nenf) is a 21 kiloDalton secreted protein with 171 aminoacids
(Kimura et al., 2005). Neudesin was classified as a member of
the membrane-associated progesterone receptor family since its
primary structure contains a cytochrome b5-heme/steroid bind-
ing domain (Kimura et al., 2012). Studies in mice showed that
neudesin is most abundantly expressed in the brain and spinal
cord (Kimura et al., 2005). While in the developing mouse brain
neudesin is predominantly expressed in neurons with scattered
presence in other cell types, in the adult brain its expression
seems to be restricted to neurons (Kimura et al., 2005). Neudesin
expression starts at approximately embryonic day 12.5 (E12.5),
as evaluated by real time PCR (RT-PCR) in neural precursor
cells; its expression increases during the rest of the embryonic
period in inverse correlation with the expression of markers of
dividing neural precursor cells (nestin) and in direct correlation
with that of microtubule-associated protein 2 (MAP-2) (a marker
for mature neurons) (Kimura et al., 2005). Of notice, neudesin
expression is higher in the cortical preplate, an area that partici-
pates in the formation of the cerebral cortex. During embryonic
and postnatal development, neurotrophic factors main func-
tions are to provide survival and differentiation of nervous cells
through activation of the p75 and tyrosine kinase (Trk) recep-
tors and by downstream pathways such as MAP and PI-3 kinases
(Russell and Duman, 2002). In adulthood, these downstream cas-
cades activate different functional responses such as axon growth,
dendrite pruning, cell fate decisions (Gray et al., 2013), as well
as the modulation of neurotransmitters, thus regulating synap-
tic plasticity (McAllister, 2001). Importantly, studies in primary
cultures of neurons revealed that neudesin display a neurotrophic
activity. Specifically, neudesin was shown to induce the prolif-
eration of cortical neural precursor cells early in development,
and their subsequent differentiation into neurons (Kimura et al.,
2005, 2006). Nevertheless, the identification of a receptor for
neudesin is still elusive. Even less information is available on the
exact function of neudesin in the adult brain, but in vitro exper-
iments indicate that it may promote the maintenance of neurons
in an autocrine/paracrine mode (Kimura et al., 2005). This neu-
rotrophic activity has been shown to depend on the attachment
of hemin to its cytochrome b5-heme/steroid domain, while a
similar relevant action on the binding of steroids failed to be
demonstrated (Kimura et al., 2008).
The importance of neurotrophic factors in brain maturation
and function was extensively demonstrated (Snider, 1994).
Furthermore, it is well-known that neurotrophic factors such as
brain derived neurotrophic factor (BDNF) and fibroblast growth
factor (FGF) play an important role in the etiology of mood
disorders, such as depression, and in modulating emotional
responses, including anxiety (Masi and Brovedani, 2011; Turner
et al., 2012). In accordance, the limbic brain regions known
to be involved in the modulation of emotional responses, that
include the ventral hippocampus, amygdala and the bed nucleus
of the stria terminalis (BNST), were shown to present an altered
neurotrophins levels after an exposure to harmful stimuli,
such as chronic stress, thus culminating in neurotransmission
imbalance and in synaptic plasticity impairment (Taylor et al.,
2011; Jung et al., 2012). Noteworthy, altered monoamin-
ergic neurotransmission was found in BDNF-null mice
(Ren-Patterson et al., 2005).
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Given the in vitro available evidence on the potential neu-
rotrophic properties of neudesin, in this study we addressed
the role of Nenf in modulating behavior (emotional and cog-
nitive) brain cytoarchitecture and neurotransmission (namely
monoaminergic), for which we used neudesin-null mice.
MATERIALS AND METHODS
ANIMALS
A mouse strain with targeted deletion of the Nenf gene, pro-
vided by Merck-Serono under a material transfer agreement, was
used. The neudesin-null (Nenf−/−) mouse strain was generated
by using a 129/SvEv genomic library from a BAC clone and
the target construct was made by deletion of the entire coding
sequence of the neudesin gene (exons 1–4, ∼12KB) and replac-
ing it by a LacZ-neomicin cassette. The BAC targeting vector was
then inserted into embryonic stem cells (FiH4 ES cells), where
the homologous pieces of DNA were recombined. The cells iden-
tified as homologous recombinant clones were microinjected into
C57BL/6F1 blastocysts to generate chimeric mouse. Initial geno-
typing was performed using a loss-of-native-allele assay. Animals
used in this study were backcrossed in a C57BL/6F background.
Nenf−/− and Nenf+/+ were obtained by crossing heterozygous
animals. Mice genotype was confirmed by PCR using two inde-
pendent sets of primers: one for the LacZ cassette, specific for the
genotype: LacZ-foward 5′-GGTAAACTGGCTCGGATTAGGG-3′
and LacZ-reverse 5′-TTGACTGTAGCGGCTGATGTTG-3′; and
another for the Nenf gene, specific for Nenf+/+ animals:
Nenf-intron3 5′- CTTGGAGTTTGGGGCTGATA-3′, Nenf-exon4
5′-TGGCTTTGTACACCTTGCTG-3′. The amplified fragments
were of 210 and 176 bp, respectively, and distinguishable by elec-
trophoresis through a 1.5% agarose gel. Confirmation of loss of
neudesin synthesis in Nenf−/− was also obtained by perform-
ing immunohistochemistry with a neudesin-specific antibody
(Sigma, St. Louis, USA) in brain samples of both control and
neudesin-null mice; neuronal expression of neudesin was not
detected in neudesin-null mice.
Neudesin-null homozygous mice are viable, fertile, grow
normally and do not display apparent morphological alter-
ations. Adult animals, at the beginning of behavioral analysis
no differences in body weight between littermate controls and
neudesin-null mice were found (Nenf+/+ = 21.13 ± 1.98 vs.
Nenf−/− = 21.28 ± 2.08 g).
Animals were maintained under 12 h light/dark cycles at
22 ± 1◦C, 55% humidity and fed with regular rodent’s chow and
tap water ad libitum. This study was approved by the Portuguese
national authority for animal experimentation, Direcção Geral
de Veterinária (permission ID: DGV9457). All experiments were
performed in accordance with the guidelines for the care and
handling of laboratory animals, as described in the Directive
2010/63/EU of the European Parliament and of the Council.
ADULT BEHAVIOR
Adult behavior was assessed in 3months-oldmalemice, in 3 inde-
pendent sets of animals, of which one is presented here. Eight
neudesin-null and 10 littermates control animals were analyzed
in the open field (OF), elevated plus maze (EPM), forced swim
test (FST) and Morris water maze (MWM) tests, performed by
this sequential order, as an initial behavioral characterization. A
24 h time interval was used between OF, EPM, and FST tests;
a 96 h time interval was used between FST and MWM. After
the first behavioral characterization, the acoustic startle (AS),
light/dark box (LDB) and novelty suppress feeding (NSF) tests
were performed, by this sequence, in order to further evaluate the
anxious-like behavior (see results section below); for this addi-
tional evaluation, another 3 independent sets of animals were
analyzed, and one representative set of 10 neudesin-null males
and 10 control littermate mice is presented here.
Adult behavior tests were performed in all animals during the
light phase of the light/dark cycle at the same period of the day to
avoid physiological differences related to the circadian cycle. The
tests were performed as described next:
Open field
Animals were placed in a room adjacent to the experimental room
1 h before the test. Locomotor activity was assessed in a brightly
illuminated square arena with 43.2 × 43.2 cm size surrounded
by walls to prevent escape. Animals were placed in the center
of the arena and allowed to explore it for 5min. Data collected
through the infrared system (MedAssociates Inc., St Albans, VT)
contained total distance travelled, and distance and time spent in
the center vs. the periphery of the arena.
Forced swim test
Animal learned helplessness behavior was analyzed using the FST
in 2 consecutive days. Mice were placed for 5min in a glass cylin-
der filled with water (24◦C) at a depth of 30 cm. Twenty-four
hours later mice repeated the test in the same conditions (Porsolt
et al., 1977). Trials were video recorded and manually analyzed
using the Etholog V2.2 software (Ottoni, 2000). The 5min of
the second day were analyzed. Data collected consisted in the
duration of swimming and of immobility time.
Morris water maze
MWM was used to evaluate mice spatial reference memory. In
this test, animals were placed in a circular white pool (170 cm in
diameter and 50 cm in height) filled with tap water (24 ± 1◦C)
placed in a poorly lit room. The pool was divided in 4 imaginary
quadrants and a transparent plexiglas platform (14 cm in diame-
ter) was hidden 0.5 cm bellow surface in the center of one of the
quadrants. For each quadrant, external clues were placed in the
walls of the room. The test consisted of 4 trials per day for 4 con-
secutive days. In each trial, animals were randomly placed in each
one of the quadrants and were allowed to swim for 120 s. Mice
that failed to reach the platformwithin this time-period were gen-
tly guided to the platform. The distance and time animals took to
find the platform were recorded using a video camera connected
to a video-tracking system (Videotrack, Viewpoint, Champagne
au Mont d’Or, France).
In the fifth day animals performed the probe and reversal tests.
The probe test consisted of a unique trial without the platform
where the animals were allowed to swim for 120 s. Time and dis-
tance swum in each quadrant were collected and analyzed for the
first 60 s. To test memory flexibility we performed the reversal test,
which consisted in changing the initial position of the platform to
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the opposite quadrant of the pool. Animals were given 3 trials of
120 s each to learn the new position. The percentage of distance
swum in each quadrant is represented.
Elevated plus maze
Anxious behavior was assessed using an apparatus composed of
two opposite brightly illuminated open arms (51 × 10 cm) and
two opposite dark closed arms (51 × 10 × 40 cm) and a central
platform, 74 cm above the floor (NIR plus maze, MedAssociates
Inc.). Animals were placed in the center of the maze and allowed
to explore it for 5min. Data collected consisted of the number of
entries (four paws) in each arm as well as the time spent in each
arm (MedPCIV, MedAssociates software).
Acoustic startle
Startle reflex was measured in a startle response apparatus
(SR-LAB, San Diego Instruments, San Diego, CA, USA), consist-
ing of a non-restrictive plexiglas cylinder (inner diameter 2.8 cm,
length 8.9 cm), mounted on a plexiglas platform and placed in a
ventilated sound-attenuated chamber. Animals were habituated
to the apparatus (5min) 1 day before actual testing. Cylinder
movements were detected and measured by a piezoelectric ele-
mentmounted under each cylinder. A dynamic calibration system
(San Diego Instruments, San Diego, CA, USA) was used to ensure
comparable startle magnitudes. Startle stimuli were presented
through a high frequency speaker located 33 cm above the star-
tle chamber. Startle magnitudes were sampled every ms over a
period of 200ms, beginning with the onset of the startle stimulus.
A startle response is defined as the peak response during 200ms
recording period. A higher startle reflex reflects an increased
anxious state of the animal.
Light/dark box
For this test the OF arena was divided in half. One part was open
and the other consisted of a black plexiglas with an entrance at the
center of the arena facing the bright side. Each animal was placed
alone at the center of the arena facing the lateral wall and allowed
to explore it for 10min. An infrared system (MedAssociates Inc)
registered the time spent in each compartment.
Novelty suppressed feeding
Animals were food deprived for 24 h before being placed in the
corner of the OF arena (MedAssociates Inc) and left to explore it
for 10min. A single pellet of food was placed in the center of the
novel environment and the latency the animal took to leave the
corner and feed was recorded. Upon reaching and start eating the
pellet the animal was placed back in the home cage, where it was
allowed to eat pre-weighted food. Food intake was recorded after
5, 15, and 30min, as a measure of appetite drive.
GOLGI-COX STAINING
One week after completion of the behavioral tests mice
(5 Nenf+/+ and 5 Nenf−/−) were transcardialy perfused with
0.9% saline under deep anesthesia and brains were removed
for Golgi-Cox staining (Gibbs et al., 1998). Briefly, brains were
immersed in Golgi-Cox solution (a 1:1 solution of 5% potassium
dichromate (Merck, Darmstadt, Germany) and 5% mercuric
chloride (Merck) diluted 4:10 with 5% potassium chromate
(Merck) for 14 d; then transferred to 30% sucrose isolution
in 0.5% sodium azide where they were kept until process-
ing. Coronal vibrotome 200µm thick sections were collected in
6% sucrose and blotted dry onto clean, gelatin-coated micro-
scope slides, alkalinized in 18.7% ammonia, developed in Dektol
(Kodak, Linda-a-Velha, Portugal), fixed, dehydrated through a
graded series of ethanol, cleared in xylene, mounted with entellan
and coverslipped.
DENDRITIC TREE ANALYSIS
Basolateral amygdala (BLa) pyramidal neurons, anterior medial
bed nucleus of the stria terminalis (amBNST), lateral dorsal
bed nucleus of the stria terminalis (ldBNST) bipolar neurons,
ventral and dorsal dentate gyrus (DG) granular and ventral CA1
pyramidal-neurons of the hippocampus were chosen randomly,
3 per section; regional boundaries were defined as previously
outlined (Dong et al., 2001; Paxinos and Franklin, 2001). The
criteria to choose perfect Golgi impregnated neurons were the
same as described previously (Uylings et al., 1986): (1) dendritic
branches were not incomplete, broken or non-impregnated;
(2) dendrites did not show overlap with other branches; (3)
neurons were visually well-isolated. Twenty five to 30 neurons per
experimental group were studied, i.e., 5–6 neurons per animal
were analyzed for each of the 5 animals in the experimental
groups. For each selected neuron, all branches of the dendritic
tree were reconstructed at 600× magnification using a motorized
microscope (BX51, Olympus), with oil objectives attached to a
camera (Microbrigthfield Bioscience, Madgedurg, Germany) and
using the Neurolucida software (Microbrightfield). Dendritical
parameters analyzed were the total dendritic length and 3D
version of the Sholl analysis (Sholl, 1956); where, the number of
dendritical intersections with concentric spheres positioned at
20µm intervals from the neurons soma was counted using the
NeuroExplorer software (MicroBrightField).
NEUROCHEMICAL ANALYSIS
Monoamines’ levels were measured using high performance liq-
uid chromatography with electrochemical detection (HPLC-ED).
Naive 3 months old male mice were killed by decapitation (10
Nenf+/+ and 8 Nenf−/−). Skulls were snap frozen in liquid nitro-
gen to avoid degradation during macrodissection. Brains were
carefully dissected for ventral hippocampus, amygdala, BNST.
Dissection was performed on ice with the help of a stereomicro-
scope.
Dissected tissues were weighed and then homogenized and
deproteinized in 100µL of 0.2N perchloric acid solution
(Applichem, Darmstadt, Germany) containing 7.9mM Na2S2O5
and 1.3mM Na2EDTA (Riedel-de Haën AG, Seelze, Germany),
centrifuged at 20000 g for 45min at 4◦C and the supernatant was
stored at −80◦C until analysis.
The analysis was performed using a GBC LC1150 HPLC
pump (GBC Scientific Equipment, Braeside, Victoria, Australia)
coupled with a BAS-LC4C (Bioanalytical Systems Inc., USA)
electrochemical detector, as previously described (Kokras et al.,
2009). The working electrode of the electrochemical detec-
tor was set at +800mV. In all samples reverse phase ion
pairing chromatography was used to assay dopamine (DA)
and its metabolites 3,4 dihydroxyphenylacetate (DOPAC) and
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homovanillic acid (HVA), serotonin (5HT) and its metabolite
5-hydroxyindoleatic (5HIAA) and norepinephrine (NE). The
mobile phase consisted of a 50mM phosphate buffer regulated at
pH 3.0, containing 5-octylsulfate sodium salt at a concentration
of 300mg/L as the ion pairing reagent and Na2EDTA at a con-
centration of 20mg/L (Riedel-de Haën AG); acetonitrile (Merck,
Darmstadt, Germany) was added at a 9% concentration. The
reference standards were prepared in 0.2N perchloric acid solu-
tion containing 7.9mM Na2S2O5 and 1.3mM Na2EDTA. The
column used was an Aquasil C18 HPLC Column, 100 × 1mm,
5µm Particle Size (Thermo Electron, UK). Samples were quan-
tified by comparison of the area under the curve against known
external reference standards using a PC compatible HPLC soft-
ware package (Chromatography Station for Windows ver.17 Data
Apex Ltd). The limit of detection was 1 pg/20µL (of injection
volume). In addition to the assay of 5-HT and 5-HIAA tissue
levels, the 5-HT turnover rate was also calculated, separately for
each chromatograph, as the ratio of 5-HIAA/5-HT. Similarly, the
ratios of DOPAC/DA and HVA/DA were calculated as an index
of DA turnover rates. Turnover rates estimate the serotonergic
and dopaminergic activities better than individual neurotrans-
mitter and metabolite tissue levels as they reflect 5-HT and DA
release and/or metabolic activity as described elsewhere (Dalla
et al., 2008; Kokras et al., 2009; Mikail et al., 2012).
STATISTICAL ANALYSIS
All values presented are expressed as the mean ± SEM and sig-
nificance was verified by using the Mann–Whitney test for inde-
pendent samples for all behavior, dendritic length, sholl analysis
and neurochemical data. Differences were considered significant
when p < 0.05.
RESULTS
ABLATION OF NEUDESIN INDUCES AN ANXIOUS-LIKE PHENOTYPE IN
ADULT MICE
Despite the described neuronal expression profile of neudesin in
the adult brain, no information is available on the relevance of
this protein for the central nervous system (CNS) functioning. To
tackle this gap we performed a wide behavioral characterization
of neudesin-null mice.
From the behavioral analyses performed we observed that the
ablation of neudesin induces a striking anxious-like phenotype
as revealed by a series of tests that specifically assess anxiety-like
behavior. We first used the EPM to analyze anxiety-like behavior
and found that the percentage of time neudesin-null mice spent
in the open arms (22%) was significantly lower than that of
controls (37%) (Figure 1A) and, conversely, more time was
spent in the closed arms (67%) when compared to controls
(50%) (p < 0.05). Of relevance, the number of entries in the
closed arms (Nenf+/+ = 10.8 ± 1.5 and Nenf−/− = 8.5 ± 1.8 s)
did not significantly differ between the groups, indicating that
the exploratory activity is preserved in neudesin-null mice.
This anxious phenotype was further confirmed in other con-
textual behavioral paradigms, namely the LDB and the NSF.
In the LDB test neudesin-null male mice spent more time in
the dark zone (396.6 ± 27.5 s) when compared to controls
(296.1 ± 25.0 s) (p < 0.05) and significantly less time in the light
FIGURE 1 | Neudesin-null mice (Nenf−/−) display an anxious-like
behavior in contextual paradigms. (A) Nenf−/− mice spend significantly
less time exploring the open arms of the EPM than control mice (Nenf+/+).
(B) The LDB test shows that Nenf−/− mice spend more time in the dark
zone than in the light zone. (C) Also, in the NSF Nenf−/− mice take longer
to feed in the novel environment when compared with Nenf+/+. (D) The AS
test shows that Nenf−/− mice have a similar startle response to higher
intensities of sound not reflecting an anxious like behavior in this anxiety
dimension. (E) In the OF no differences were observed between Nenf−/−
and Nenf+/+ in the total distance traveled in the arena. (F) Performance in
the FST, which assessed learned helplessness behavior does not reveal
differences between the two groups. (G) Cognition, as assessed using the
MWM test, is identical between groups, as revealed by the time taken to
learn the platform position. (H) The % of distance swum in the new
quadrant in the reversal trials of the MWM test did not reveal any
differences between groups. Data are presented as mean ± SEM.
∗p < 0.05. OA, open arms; CA, closed arms; H, hub; DZ, dark zone; LZ,
light zone?
zone (Nenf+/+ = 303.4 ± 24.9 vs. Nenf−/− = 202.8 ± 27.5 s)
(p < 0.05) (Figure 1B); importantly there were no differences
regarding the total distance travelled (data not shown). In the
NSF test animals have an extra motivational cue—they are fas-
tened for 24 h—so when they are placed in a novel environment,
the latency to feed is a measurement of anxiety. In this test we
observed that neudesin-null mice displayed increased latency
time to eat in the OF arena (416.8 ± 63.6 s) when compared to
controls (253.8 ± 35.9 s) (p < 0.05) (Figure 1C). The previously
described tests are based on conflicts between the animal’s innate
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exploratory/feeding behavior and its aversion for open brightly
lit spaces. These are often considered tests for state anxiety and
are dependent on cortical processing. On the other hand, the
AS test is based on a reflex response to aversive stimuli that
tests for a different dimension of anxiety, a more generalized
and innate response—trait anxiety. Therefore, a more anxious
animal will respond with a bigger startle at higher intensities
of sound. Interestingly, the AS test failed to show an anxious
like behavior in neudesin-null mice (Figure 1D), even at the
higher intensities of sound (120 dB) (Nenf+/+ = 22.37 ± 3.26
vs. Nenf−/− = 23.45 ± 3.29ms) (Figure 1D).
Regarding other behavioral traits, neudesin-null mice did not
reveal any phenotype. The OF arena was used to assess loco-
motor activity. The analysis revealed that neudesin-null mice
did not display motor impairments, when compared to control
animals (Figure 1E). We used the FST to measure helplessness
behavior, a behavioral dimension relevant for depression. In the
FST (Figure 1F) both controls and neudesin-null animals spent
a similar amount of time immobile (Nenf+/+ = 229 ± 5 vs.
Nenf−/− = 225 ± 8 s), thus indicating that neudesin-null mice
do not display a depressive-like behavioral phenotype. Cognition,
specifically spatial reference memory, was analyzed in the MWM.
Both neudesin-null and control mice learned the position of the
hidden platform as they similarly decreased the latency of time
required to perform the task, indicating an absence of cognitive
impairment (Figure 1G); this was further confirmed in the probe
test (data not shown). Regarding performance in the reverse
learning task of the MWM, the percentage of distance swum in
the new quadrant by neudesin-null mice was similar to that of
control mice (Figure 1H).
NEUDESIN-NULL ADULT MALE MICE HAVE ALTERED NEURONAL
MORPHOLOGY
Neuronal morphology, dendrite formation and the establishment
of synaptic contacts are dependent of trophic support. Due to the
potential role of neudesin as a neurotrophic factor we studied the
3D-morphology of neurons in neudesin-null mice. In light of the
anxiety-like phenotype described before, we focused the analysis
in brain regions implicated in the modulation of this behavioral
trait, namely the ventral hippocampus, the amygdala (BLa nuclei)
and the BNST. When compared to control mice, neudesin-null
mice presented shorter dendritic length of ventral hippocampal
DG granular neurons (Nenf+/+ = 741.8 ± 32.8 vs. Nenf−/− =
463.9 ± 83.3µm) (p < 0.05) (Figure 2A left panel). Sholl analy-
sis also revealed fewer intersections of the dendritic tree (with the
imaginary spheres) at distances between 60 and 120µm from the
soma in neudesin-null mice (p < 0.001) (Figure 2A right panel).
Nevertheless, in ventral hippocampal CA1 pyramidal-like neu-
rons no difference was found between control and neudesin-null
mice in dendritic length or dendritic arborization, both for the
basal and for the apical dendrites (Figure 2B). Noteworthy the
differences found for ventral hippocampal DG neurons were not
observed in the dorsal DG granular neurons (Nenf+/+ = 644.7 ±
29.3 vs. Nenf−/− = 606.3 ± 39.9µm). Regarding the BNST, two
different divisions were analyzed, the anterior medial BNST
(amBNST) and the lateral dorsal BNST (ldBNST); neudesin-null
mice had a statistically significant reduction in dendritic length
in the anterior medial (Nenf+/+ = 584.8 ± 36.7 vs. Nenf−/− =
412.6 ± 14.7µm) (Figure 2C left panel), but no differences in the
lateral dorsal division (Nenf+/+ = 628.7 ± 64.5 vs. Nenf−/− =
485.2 ± 34.1µm), as well as no differences regarding dendritic
arborization of neurons in both BNST divisions. Finally, the mor-
phology of pyramidal-like neurons of the BLa was analyzed and
no differences were observed between control and neudesin-null
mice (Figure 2D).
NEUROTRANSMITTER ACTIVITY PROFILE IN ANXIETY RELATED
REGIONS
Given the behavioral and structural alterations found in
neudesin-null mice we next characterized the monoaminergic
profile (major findings presented Table 1 for complete data) of
several anxiety-related brain regions (amygdala, BNST, ventral
hippocampus). We observed a reduction of DA levels in the ven-
tral hippocampus of neudesin-null animals (p < 0.05) (Table 1),
which was accompanied by an elevated dopaminergic turnover of
HVA/DA (p < 0.05) (Table 1). Regarding the amygdala, there was
a trend for a reduction in DA, DOPAC, and NE levels (Table 1);
in the BNST no alterations were observed in monoamines levels
or turnover (Table 1).
Regarding serotonin, a significant reduction of the serotonin
metabolite 5HIAA (p < 0.05) (Table 1) was seen in the ven-
tral hippocampus, but this difference did not translate into any
alterations regarding serotonin turnover. An ∼40–50% reduc-
tion in the levels of both 5HT and 5HIAA in neudesin-null mice
was also observed in the amygdala but these differences did not
reach statistical significance for both metabolites. In the BNST
no differences were observed for 5HT metabolites and respective
turnover rates.
DISCUSSION
This work provides the first in vivo demonstration of the relevance
of the neurotrophic factor neudesin for CNS normal function. In
the absence of neudesin, mice display a contextual anxious like
phenotype that is accompanied by impairment in the dopamin-
ergic activity of the ventral hippocampus, where the dendritic
arborization in granular neurons branching is impoverished; in
addition, they also present a dendritic atrophy in the amBNST
nucleus.
We first addressed the role of neudesin by exploring the
behavioral consequences of its ablation. Of the several behav-
ioral dimensions assessed, only anxiety-related phenotypes were
clearly affected by the absence of neudesin, as demonstrated by
the shorter time spent in the open arms of the EPM and in the
light zone of the LDB and the higher latency to eat in the NSF
test. Interestingly, no deficits were found in the AS, which reveals
that the increased anxiety occurs specifically in contextual conflict
paradigms, described to involve modulation by different neu-
ronal circuits (Koch and Schnitzler, 1997). Anxiety in the presence
of contextual anxiogenic environments, such as those observed
here, is shown to be mediated by the BNST (Ventura-Silva et al.,
2012) under the modulation of different cortical regions namely
the hippocampus and the prefrontal cortex (Ventura-Silva et al.,
2013). The BNST is closely involved in stress and in the HPA
axis-dependent modulation of emotional behaviors (Herman and
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FIGURE 2 | Three-dimensional morphometric analysis of Golgi-Cox
impregnated neurons of the ventral hippocampus, BNST and
amygdala. Nenf−/− mice have shorter dendrites than controls in the
dentate gyrus (DG) of the ventral hippocampus (A, left panel) as well
as less intersections between dendrites (A, right panel). These
differences in dendrite morphology and neuron arborization are not
observed for the hippocampal CA1 region (B, left and right panel,
respectively). Neudesin-null mice have shorter dendritic length in the
anterior medial division of the BNST (amBNST) and no differences in
the number of intersections in the sholl analysis (C, left and right
panel, respectively). Analysis of the basolateral nucleus of the amygdala
(BLa) revealed no differences concerning dendritic length or arborization
(D, left and right panels, respectively). The middle panels correspond to
a representative 3D reconstructed neuron from each region analyzed
from both Nenf+/+ (left) and Nenf−/− (right). Data are presented as
mean ± SEM. ∗p < 0.05.
Cullinan, 1997). It has been reported that anxiety triggered by
different stress-inducing paradigms is related to hypertrophy of
the amBNST neurons (Pego et al., 2008; Oliveira et al., 2012).
Surprisingly, however, neudesin-null mice display shorter den-
drites in the amBNST, which suggests this might be a stress-
specific effect and that other factors beyond the pure structure
of these neurons might underlie the behavioral changes displayed
by neudesin-null mice.
Interestingly, the same holds true for the ventral hippocam-
pus, where we also found dendritic atrophy, specifically in granule
cells. The role of the ventral hippocampus in anxiety has been a
matter of debate, with some studies showing that an increased
activity in this brain region is related with increased emotionality
(McHugh et al., 2004, 2011), while others studies do not confirm
this association (Marrocco et al., 2012). Recently, however, the
activity of ventral granule cells has been specifically implicated
in anxiety behavior. Using optogenetics tools to activate and to
inhibit DG granular cells in the ventral hippocampus, Fournier
et al saw that elevating activity in this area suppresses anxiety in
the EPM (Fournier and Duman, 2013). The present results seem
to support the later study, in as much as we show that neudesin-
null mice present an impoverished arborization in granule cells
of the ventral hippocampus. Noteworthy, this later effect is spe-
cific to the ventral hippocampus since we found no differences
between control and neudesin-null mice in the arborization of
dorsal DG granular cells. Given the recently shown role of dorsal
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Table 1 | Levels of monoamines in brain areas of littermate control
(Nenf+/+) and neudesin-null (Nenf−/−) mice.
Nenf+/+ Nenf−/−
VENTRAL HIPPOCAMPUS
NE 1.49±0.22 1.06±0.31
DA 0.49±0.10 0.27±0.09*
DOPAC 0.43±0.15 0.35±0.15
HVA 0.32±0.06 0.27±0.10
DOPAC/DA 0.78±0.13 1.17±0.22
HVA/DA 0.61±0.07 1.02±0.08**
5HT 8.69±1.51 5.21±1.31
5HIAA 10.59±2.40 6.28±1.92*
5HIAA/5HT 0.94±0.09 1.08±0.09
BED NUCLEUS OF THE STRIA TERMINALIS
NE 9.44±1.49 13.58±4.33
DA 6.77±1.51 9.54±3.85
DOPAC 8.32±2.57 9.89±3.95
HVA 5.38±1.15 6.52±1.85
DOPAC/DA 0.96±0.10 1.33±0.20
HVA/DA 0.72±0.10 1.16±0.21
5HT 13.12±3.69 16.12±4.88
5HIAA 6.72±1.41 9.80±2.35
5HIAA/5HT 0.60±0.06 0.72±0.07
AMYGDALA
NE 2.50±0.69 1.57±0.41
DA 6.76±1.56 3.00±1.09
DOPAC 7.54±2.40 3.16±0.86
HVA 3.33±1.04 1.38±0.35
DOPAC/DA 0.99±0.14 1.38±0.45
HVA/DA 0.50±0.07 0.56±0.12
5HT 15.08±3.31 6.50±0.98
5HIAA 10.15±2.81 5.97±1.58
5HIAA/5HT 0.64±0.07 0.91±0.21
Levels of catecholamines and monoamines are in µg/g tissue and expressed as
means ± S.E.M. *p < 0.05 and **p < 0.01.
DG cells in the modulation of learning (Kheirbek et al., 2013),
this result is in accordance with the absence of a cognitive pheno-
type in neudesin-null mice. This specific alteration in the atrophy
of DG granule cells along the dorsal-ventral axis in the absence of
neudesin is of relevance and deserves further investigation.
Going further into the molecular levels, we next studied
the monoaminergic profile of anxiety-related brain regions.
Interestingly, the absence of neudesin is associated with low lev-
els of DA and increased HVA/DA turnover ratio in the ventral
hippocampus. Importantly, DA levels are described to be higher
in the ventral than in the dorsal hippocampus (Eisenhofer et al.,
2004) and DA is known to play a crucial role in modulating plas-
ticity in the ventral portion of the hippocampus (Belujon and
Grace, 2011). In addition, dopamine 1 receptor (D1) is highly
expressed in the dendrites of the granular cells of the ventral
DG (Mansour et al., 1992), and dopamine release from project-
ing ventral tegmental area neurons impacts on the modulation
of synaptic plasticity and synapse strenght in this brain region
(Hamilton et al., 2010). Whether decreased DA release in the
ventral hippocampus, as observed in neudesin-null mice, con-
tributes to the dendritic atrophy in ventral DG granular neurons
is unknown. Nevertheless, the role of dopamine in anxiety is
also endowed in controversy: while pioneer studies with systemic
apomorphine (a D1/D2 agonist) administration were shown to
decrease anxiety (Hjorth et al., 1986), more recent studies using
specific administration of this drug in the ventral hippocampus
increased anxiety in the EPM (Zarrindast et al., 2010). Regarding
the levels of 5HT, it is of notice that the ventral hippocampus of
neudesin-null mice displays a decrease (although not significant)
of 40% in the levels of 5HT and a sharp reduction in the levels
of its derived metabolite 5HIAA. This is of relevance since selec-
tive knock-down of auto 5HT-1A receptors in the raphe nuclei
of mice results in a direct increase of anxiety levels in contextual
paradigms, and in a concomitant decrease in the extracellular lev-
els of 5HT in the ventral hippocampus (Richardson-Jones et al.,
2011). Thus, the alteration in serotonergic metabolites observed
in the ventral hippocampus may contribute to the anxiety state
observed in neudesin-null mice, in accordance to previous studies
in stressed animals (Dalla et al., 2008). Also interesting, although
not significant, is the reduction in the 5HT levels in the amygdala
of neudesin-null mice. This may be of relevance when considering
the fundamental role of 5HT as a player in the crosstalk between
amygdala and the ventral hippocampus in themodulation of anx-
iety behavior (Asan et al., 2013). Overall, these results further
highlight a possible role for neudesin in the establishment and/or
maintenance of hippocampal circuitry and in the modulation of
contextual anxiety-behavior.
Both during embryonic and postnatal brain development sev-
eral external signals including neurotrophic factors, neurotrans-
mitters and hormones are involved in the genesis and maturation
of new neurons and in their integration into functional circuitries
(Abrous et al., 2005). One of the unique roles previously ascribed
to neudesin, as shown in vitro, is its neurotrophic activity (Kimura
et al., 2005, 2006). Thus, it is plausible that the herein described
functional alterations in neuronal arborization result from the
absence of neurotrophic support conveyed by neudesin. On the
other hand, neudesin structure displays a heme and/or steroid-
binding site (Kimura et al., 2005), which seems necessary for its
function (Kimura et al., 2008). Free heme is a powerful oxida-
tive stressor (Jeney et al., 2002; Craven et al., 2007; Abraham and
Kappas, 2008) and under physiological conditions it is bound to
extracellular heme binding proteins such as Nenf. Thus, we can-
not discard the possibility that the deleterious effects of free heme
due to the absence of neudesin might have implications in the
maintenance of neurons as previously suggested (Burmester and
Hankeln, 2004).
The data presented in this study suggest that neudesin modu-
lates anxiety behavior mainly through the DG ventral hippocam-
pus and altered dopaminergic activity. Thus, the neurotrophic
action described previously for neudesin per ser, or in association
with its ligands, might be of therapeutical and/or pharmacolog-
ical potential in anxiety-related disorders. The modulatory role
of neudesin in anxiety might be associated with its putative neu-
rotrophic role but why this effect is specific for the anxiety circuits
is still to be determined. Nevertheless, since the mouse model
used in this study is a constitutive knock-out of the Nenf gene, we
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cannot exclude potential developmental determinants (Stevens
et al., 2010) resulting from the absence of neudesin in adult
anxiety circuits, which should next be investigated.
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Abstract 
Neudesin (NENF), a neuron-secreted protein, with a distinctive cytochrome b5-like heme/steroid-
binding domain, that belongs to the membrane-associated progesterone receptor family, displays 
neurotrophic proprieties. Nevertheless, information regarding neudesin function is scarce. In vitro 
evidences show that nenf modulates proliferation and differentiation of mice cortical neurons in 
specific time windows. Nenf expression and neurotrophic activity appears to be restricted to 
neurons. In fact, Nenf mRNA is described to be more abundant in embryo brain and spinal cord, 
but also in postnatal organs, including brain. The presence of NENF on mouse embryonic brain 
suggests a role for nenf during development. In this study we aimed at exploring if the absence of 
Nenf impairs brain physiology and function, namely in behavior. We performed developmental 
milestones of neudesin-null mice to evaluate the correct acquisition of age specific neurological 
functions. The early postnatal neurological reflexes have specific time windows of maturation. A 
delay in the correct acquisition of these developmental hallmarks, although transient, can reveal 
impairments in more mature functions. This broad characterization was performed during the 
first 21 postnatal days. 
We observed sex differences between neudesin-null and control animals, namely a delay in the 
acquisition of 3 of the 5 vestibular dependent tests. These alterations indicate altered vestibular 
system function, the area responsible for providing the correct information about spatial and 
movement position of the body and one of the brain regions that mature in first 3 weeks of 
postnatal life. Furthermore, we tackled these behavior differences with a monoaminergic profile 
of related brain regions, which revealed that the brain stem of neudesin-null males present 
increased serotonin and decreased serotonergic activity this was also observed in the 
cerebellum. It was also observed an increase in the levels of norepinephrine in the brain stem 
while it was decreased in the motor cortex. Regarding dopaminergic activity, it is decreased in the 
vestibular area and the cerebellum. These delays and the neurochemical alterations observed 
can have implications in adult behavior dimensions, contributing to unravel the function of 
neudesin in the nervous system. 
 
 
  
 51 
Introduction 
Neurotrophic factors are important for nervous cells function and homeostasis from embryonic 
stages through adulthood (Park and Poo, 2013). In fact, several in vivo studies using knockout 
and transgenic mice for specific neurotrophic factors and/or the respective receptors have 
contributed to demonstrate the importance of this protein family during diverse brain 
developmental stages. For instance, the absence of particular neurotrophic factors, such as 
nerve growth factor (NGF), brain derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), 
yields mild to severe impairment in the development of the CNS (Snider, 1994;Tessarollo, 
1998;Binder and Scharfman, 2004;Binder, 2007;Iwata and Hevner, 2009).  
Similarly to several neurotrophic factors, neudesin (also known as neuron derived neurotrophic 
factor, NENF) was shown to be a secreted protein that displays trophic actions in neuronal cells 
(Kimura et al., 2005). Namely, using different in vitro approaches, it was shown that NENF is 
able to potentiate the proliferation of primary cell cultures of mouse embryonic cortex in a dose 
dependent manner, and differentiate them only into neurons and not astrocytes, throughout the 
involvement of MAP kinase, PI-3 kinase and PKA pathways (Kimura et al., 2006). Furthermore, 
NENF promoted mitogenic activity in primary cultures of neurons but not in astrocytes; this 
activity was shown to occur via the activation of MAP kinase and PI-3 Kinase pathways and 
inhibited by the inhibition of Gi/Go-protein-coupled receptor. Of notice, NENF displays a 
cytochrome b5-like heme/steroid-binding domain in its primary structure and it was shown in 
vitro that heme-binding was relevant for neudesin neurotrophic actions (Kimura et al., 2008). 
While in adult mice (PND49), Nenf is expressed in other tissues such as the heart, lungs, kidney 
and brain, during embryonic development (E18.5) it is highly expressed specifically in the brain 
and spinal cord (Kimura et al., 2005). During embryonic development, Nenf expression increases 
from E12.5 until E18.5 in the mouse cerebral cortex, and the main region expressing mouse 
Nenf at E13.5 stage is the preplate, where most post mitotic neurons exist (Kimura et al., 2006). 
In adulthood we have shown that Nenf is involved in the modulation of anxiety circuitries. 
Specifically, in the absence of neudesin, mice display an anxious-like phenotype exclusively in 
novel contextual paradigms of anxiety. This behavioral impairment was correlated with an 
imbalance of the monoaminergic system in brain regions involved in the control of emotional 
responses. Furthermore, NENF was shown to be relevant for the proper arborization of ventral 
hippocampus and bed nuclei of the stria terminalis (BNST) neurons (Novais et al., 2013).  
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Although several lines of evidence support the potential relevance of neudesin for the nervous 
system development this was still not demonstrated. This is of relevance since abnormal 
development of neural circuitries makes individuals prone to neuropsychiatric disorders (Cicchetti 
and Walker, 2003). In order to evaluate the postnatal development of neudesin-null mice, we 
used a set of specific behavioral paradigms to analyze the neurological early postnatal 
development of mice (Fox, 1965;Santos et al., 2007;Lim et al., 2008;Castelhano-Carlos et al., 
2010). Furthermore, we have analyzed the neurochemical profile of the monoaminergic system 
in brain regions involved in the maturation of neurological postnatal milestones. 
 
Methods 
Animals 
A mouse strain with targeted deletion of the neudesin gene, provided by Merck Serono under a 
material transfer agreement, was used in all experiments. Briefly, the neudesin-null mouse strain 
was generated by using a 129/SvEv genomic library from a BAC clone and the targeting 
construct was made by deleting the entire coding sequence (exons 1 to 4, approximately 12KB) 
and replacing it with a LacZ-neomicin cassette. The target DNA was then inserted into embryonic 
stem cells (FiH4 ES cells), where the homologous pieces of DNA recombined. The cells identified 
as homologous recombinant clones were microinjected into C57BL/6F1 blastocysts to generate 
chimeric mouse and then backcrossed to a C57BL6 background.  
Animals were maintained under 12h light/dark cycle at 22±1OC, 55% humidity and fed with 
regular rodent’s chow and tap water ad libitum. The Portuguese national authority for animal 
experimentation - Direcção Geral de Veterinária - approved the study (permission ID: DGV9457). 
All experiments were performed in accordance with the guidelines for the care and handling of 
laboratory animals in the Directive 2010/63/EU of the European Parliament and of the Council. 
Neudesin null mice (Nenf-/-) and their respective littermate controls (Nenf+/+) were obtained by 
mating Nenf+/- females with Nenf+/- males. Mice genotype was confirmed by PCR using two sets of 
primers. One for the lacZ cassette: lacZ-Forward 5’- GGTAAACTGGCTCGGATTAGGG -3’, lacZ-
Reverse 5’- TTGACTGTAGCGGCTGATGTTG -3’ and another for the nenf gene, nenf_intron 3 5’- 
CTTGGAGTTTGGGGCTGATA -3’, nenf-Exon 4 5’- TGGCTTTGTACACCTTGCTG -3’. The amplified 
fragments were of 210bp and 176bp, respectively, and identified by electrophoresis through a 
1.5% agarose gel.  
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Developmental milestones 
Developmental milestones were performed in 26 males and 26 females, 16 Nenf-/- (8 females 
and 8 males) and 36 Nenf+/+ (18 females and 18 males) from nine different litters. Neonatal 
neurodevelopmental behavior was evaluated by using an adapted protocol that was previously 
validated in mice (Fox, 1965;Santos et al., 2007;Lim et al., 2008;Castelhano-Carlos et al., 
2010). Briefly, after birth animals were daily observed and scored for the acquisition of maturity 
in somatic parameters, reflexes, strength, coordination and spatial reference tests during the first 
21 postnatal days. The researcher performing the assay was blind for animal’s genotype during 
the protocol. Specifically, the following parameters were evaluated. 
Somatic parameters 
Newborn animals were examined daily for correct maternal care and well being, skin 
appearance, activity and presence of milk in the stomach (milk spot) to confirm feeding. Animals 
were weighted and anogenital distance (ANGD) was measured daily. From PND1 onwards 
animals were observed for eye opening, defined as the initial break in the membrane sealing the 
lids of both eyes, fur appearance and incisor eruption.  
Neurological reflexes 
The evaluation of neurologic reflexes was performed daily from PND 1 to PND 21 at the same 
circadian rhythm hour (2-4 pm). The cages were taken from the housing room and the pups 
were left in the same room as the mother during the tests and returned to the mother’s cage 
immediately after the tests ended. A list and brief description of the tests performed follows. 
Cliff aversion: From PND1 to 14. Tests for spatial reflex and coordination. Animals were placed 
on the edge of a cliff (box) with forepaws and face over the edge. Mature response was observed 
when the animals turn and crawl away from the cliff.  
Negative geotaxis: From PND1 to 14. Tests for spatial, body righting and labyrinthine 
mechanisms. Animals were placed face down on a 45O grid. Mature response was observed 
when animals turn 180O up and walk to the top of the grid. 
Surface righting: From PND1 to 13. Tests for spatial, body righting and labyrinthine mechanisms. 
Animals were placed in their back in the table. Mature response was observed when the animals 
turns to normal position in 4 paws.  
Wire suspension: From PND5 to 14. Tests for strength. Animals were placed vertically to hold a 2 
mm metal bar with forelimbs. Mature response was observed when animals could hold body 
weight alone without falling.  
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Walking: From PND5 to 21. Tests for locomotion and coordination. Progression of animals 
pivoting to crawling and finally walking was analyzed. Mature response was observed when 
animals walk straight forward with 4 paws.  
Grasping: From PND4 to 18. Tests for strength. Animals forelimb was stroked with a blunt 
instrument. Mature response was observed when animals flex paws and grasp instrument.  
Postural reflex: From PND5 to 21. Tests for spatial and body righting mechanisms. The animal s 
were placed inside a box and gently shaken up and down, left and right. Mature response was 
observed when animals maintain straight posture by opening the base between limbs.  
Auditory startle: From PND7 to 18. Tests for auditory reflex. Startle response observed after a 
handclap.  
Ear twitch: From PND7 to 15. Tests for tactile and auditory reflex. With the end of a cotton tip, 
animals ear was scrubbed. Mature response was observed when animals flat the ear against the 
side of the head.  
Air righting: From PND8 to 21. Tests for spatial and body righting mechanisms. Animals was held 
upside down at a 13cm distance from the bedding and dropped. Mature response was observed 
when animals lands on four paws.  
Developmental milestones were evaluated according to a score for each test. Tests that 
evaluated presence/no presence were scored as 1/0 (rooting, wire suspension, postural reflex, 
eye opening, ear twitch, auditory startle, air righting). The tests where a gradual evolution was 
observable were scored from 0 to 3 (cliff aversion, negative geotaxis, surface righting, walking, 
grasping), with 0 being not present and 3 being mature response. 
 
Neurochemical analysis  
Monoamines’ levels were measured using high performance liquid chromatography with 
electrochemical detection (HPLC-ED). Male mice after developmental milestones protocol at 
PND21 were killed by decapitation (Nenf-/-=8 and Nenf+/+=10). Skulls were snap frozen in liquid 
nitrogen to avoid degradation during macrodissection. Brains were carefully dissected for 
cerebellum, brainstem, vestibular area and motor cortex on ice and with the help of a 
stereomicroscope (SZX7; Olympus).  
Dissected tissues were weighed and then homogenized and deproteinized in 100 µL of 0.2 N 
perchloric acid solution (Applichem, Darmstadt, Germany) containing 7.9 mM Na2S2O5 and 1.3 
mM Na2EDTA (Riedel-de Haën AG, Seelze, Germany), centrifuged at 20000 g for 45 min at 4°C 
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and the supernatant was stored at - 80°C until analysis. 
The analysis was performed using a GBC LC1150 HPLC pump (GBC Scientific Equipment, 
Braeside, Victoria, Australia) coupled with a BAS-LC4C (Bioanalytical Systems Inc., USA) 
electrochemical detector, as previously described (Kokras et al., 2009). The working electrode of 
the electrochemical detector was set at +800 mV. In all samples reverse phase ion pairing 
chromatography was used to assay dopamine (DA) and its metabolites 3,4 
dihydroxyphenylacetate (DOPAC) and homovanillic acid (HVA), serotonin (5HT) and its metabolite 
5-hydroxyindoleatic (5HIAA), and norepinephrine (NE). The mobile phase consisted of a 50 mM 
phosphate buffer regulated at pH 3.0, containing 5-octylsulfate sodium salt at a concentration of 
300 mg/L as the ion pairing reagent and Na2EDTA at a concentration of 20 mg/L (Riedel-de 
Haën AG); acetonitrile (Merck, Darmstadt, Germany) was added at a 9% concentration. The 
reference standards were prepared in 0.2 N perchloric acid solution containing 7.9 mM Na2S2O5 
and 1.3 mM Na2EDTA. The column used was an Aquasil C18 HPLC Column, 100 mm X 1 mm, 
5 µm Particle Size (Thermo Electron, UK). Samples were quantified by comparison of the area 
under the curve (AUC) against known external reference standards using a PC compatible HPLC 
software package (Chromatography Station for Windows ver.17 Data Apex Ltd). The limit of 
detection was 1 pg/20 µL (of injection volume). In addition to the assay of 5-HT and 5-HIAA 
tissue levels, the 5-HT turnover rate was also calculated, separately for each chromatograph as 
the ratio of 5-HIAA/5-HT. Similarly, the ratios of DOPAC/DA and HVA/DA were calculated as an 
index of DA turnover rates. Turnover rates estimate the serotonergic and dopaminergic activities 
better than individual neurotransmitter and metabolite tissue levels as they reflect 5-HT and DA 
release and/or metabolic activity as described elsewhere (Dalla et al., 2008;Kokras et al., 
2009;Mikail et al., 2012). 
 
Statistical analysis 
Values presented in table 1 are expressed as mean±standard deviation and significance was 
verified by using the Mann-Whitney test for independent samples. Differences were considered 
significant when p<0.05.  Monoamines quantification are expressed as mean±standart error of 
the mean (SEM) and significance was verified by the Mann-Whitney test for independent 
samples. The day in which each animal achieves maturity for each test has been normalized to z-
scores; z-normalization is a methodology that standardizes observations obtained at different 
times. It indicates how many standard deviations and animal performance is above or below the 
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mean. We used this normalization factor since we have used animals from 9 different litters 
(always with the same observer). By calculating z-scores for each individual vestibular and 
strength test, we then calculated the average of each z-score values across tests, which lessens 
potential biases induced by a single test. Vestibular score was calculated from the average scores 
of the cliff aversion, surface righting, air righting, postural reflex and negative geotaxis tests; the 
strength score was calculated from the scores on the walking, grasping and wire suspension 
tests. 
 
Results 
 
Neudesin-null animals somatic development 
All newborn mice of both genders and genotypes were observed daily, for the first 21 days of 
early life. Somatic parameters, such as body temperature, milk spot and anogenital distance, 
were observed and no differences were found between mouse genotypes, suggesting a correct 
maternal care and well being of all litters analyzed.  
Neudesin-null males and females gain body weight in a healthy manner (figure 1A and B) but a 
significant difference between neudesin-null males and their respective control littermates was 
found from PND19 to PND21 (p<0,05) (figure 1A). Nonetheless, this weight difference is 
transitory since in adulthood it is not present (data not shown). ANGD was measured as a 
parameter of animal growth. ANGD did not differ between sex and genotype demonstrating that 
no abnormalities concerning general growth were observed (figure 1C and 1D). Regarding eye 
opening, besides previously described inherent differences between males and females 
(Cancedda et al., 2004), no significant differences were observed between genotypes, although 
neudesin-null females when compared to littermate controls show a slighter but non-significant 
delay (figures 1E and F). 
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Figure 1 - Evaluation of somatic parameters during the developmental milestones protocol in 
neudesin-null mice (Nenf-/-) and littermate controls (Nenf+/+). A diminished body weight in the days previous 
to weaning was observed in neudesin-null male mice (A) but not in females (B). The anogenital distance (ANGD) was 
also measured during the 21 days of protocol in males (C) and females (D) with no differences being observed 
between genotypes. The percentage of animals that open both eyes per postnatal day in males (E) and females (F) 
does not significantly differ between Nenf-/- and Nenf+/+ mice. Values are means±SEM except for E and F. * p<0.05. 
 
Neudesin-null males have a mild developmental neurologic delay  
Sensory-motor reflexes, locomotion, coordination and strength milestones were analyzed and 
compared between neudesin-null mice and control littermates. The neurologic developmental 
milestones tests performed fit 3 categories: vestibular area dependent (cliff aversion, surface 
righting, air righting, postural reflex and negative geotaxis); strength and motor dependent 
(walking, grasping and wire suspension) and auditory dependent (auditory startle and ear twitch). 
Mean days of mature response for all performed milestones are summarized in table 1. All 
animals reached mature scores for all tests performed during the period analyzed (0-3 weeks). 
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Regarding vestibular area dependent tests, we observed that neudesin-null males displayed an 
overall delay in the acquisition of maturity when compared to control littermates, but the same 
was not observed in females (figure 2). Nevertheless, in some tests, namely the cliff aversion test 
(figure 2A and 2B) and the surface righting test (figures 2C and 2D), the percentage of neudesin-
null mice that reach maturity earlier than their control littermates was slightly higher. 
Nevertheless, these differences between genotypes did not reflect a significant delay in the 
acquisition of these reflexes when the average day of maturity is calculated for both genders 
(table1). On the other hand, the remaining vestibular area dependent tests, showed that 
neudesin-null mice have a marked delay in the acquisition of these reflexes as evaluated by both 
the percentage of animals reaching maturity in a given day of test and the average day of 
maturity, but, interestingly only in males (figure 2E, 2G, 2I and table 1). In fact, while in the air 
righting test, only males showed a significant delay (Nenf+/+=PND11 vs Nenf-/-= PND13) (p<0.05) 
(table1, figure 2E), the same was not observed in neudesin-null females in the acquisition of this 
reflex (table1, figure 2F). Similarly, in the postural reflex, neudesin-null males achieved maturity 
on average only at PND9 while control littermates reached maturity earlier at PND6 (p<0,001) 
(table1 and figure 2G); in the case of the postural reflex, a comparable delay (Nenf+/+=PND7 vs 
Nenf-/-= PND9) was observed in females (figure 2H) but it did not reach significance (table 1). In 
the negative geotaxis test, neudesin-null males showed a significant delay when compared to 
controls (Nenf+/+=PND7 vs Nenf-/-=PND9) (p<0.05), but this difference was not observed in 
females (table1 and figures 2I and 2J). Overall neudesin-null male mice achieved maturity with a 
significant delay in 3 of the 5 developmental milestones evaluated, while neudesin-null females 
did not show any significant delay in the same tests. Regarding motor tests, namely the walking 
test, no difference between genotypes was observed in the first time animals walked with four 
paws without dragging the belly. In the grasping test, both genotypes and genders reached 
maturity approximately at PND13 (table1). In the wire suspension test, that tests forelimb paw 
strength, both neudesin-null males and females achieved maturity, but not significantly, earlier 
than littermate controls (table1). Besides tests that evaluate vestibular and motor function, we 
tested other dimensions of postnatal neurodevelopment. In the auditory startle response, that 
reflects the opening of the ear canal, only neudesin-null male mice showed a mild delay 
achieving maturity, with at PND15 100% of controls having the ear canal open comparing to only 
75% of neudesin-null mice; maturity in all (100%) neudesin-null male mice was only achieved at 
PND18; however this difference is not significant (table1). In females this difference was not 
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present and neudesin-null females even achieve maturity slightly earlier than controls (table1). In 
the ear twitch, neudesin-null mice revealed a minor delay in the acquisition of this tactile reflex 
(not significant) in both males and females (table1). Overall, the ablation of NENF had an impact 
in the timely acquisition of development milestones in males, but not in females. 
 
 
Males Females 
Parameters Nenf+/+ Nenf-/- Nenf+/+ Nenf-/- 
Weigth (g)   8,4±0,8   7,2±1,1*   8,3±1,0   8,3±1,0 
Eye Opening 13,5±0,8 13,9±1,1 13,7±0,7 14,1±1,1 
Cliff Aversion  9,3±1,8   8,4±1,5   9,4±3,2   7,1±2,6 
Surface righting  7,3±1,8   7,0±1,6   7,0±2,1   5,4±0,8 
Air righting 11,3±2,0   13,5±2,0* 12,7±2,0 12,1±2,1 
Postural Reflex   5,8±1,1      9,5±1,9**   7,2±1,5   8,6±1,3 
Negative Geotaxis  6,9±1,2    9,0±0,8*   8,4±1,6   8,4±2,0 
Auditory Startle 13,8±1,2    15±2,1 14,4±1,3 13,2±2,0 
Ear twitch 10,9±1,1 12,1±0,6 11,4±0,8 12,3±1,7 
Grasping 13,9±2,2 12,8±2,3 12,5±1,7 13,2±1,1 
Wire suspension  9,4±1,3   9,0±2,2   8,9±1,2   7,0±1,2 
Walking  9,7±1,4   9,6±1,5   9,5±1,9 10,2±1,9 
Mean ± SD; *p<0.05; **p<0.001 
 
Table 1 – Summary of developmental milestones average maturation day and body weight (at PND21) for 
males and females neudesin-null (Nenf-/-) and littermate control (Nenf+/+) mice. 	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Figure 2 - Neudesin ablation resulted in a delay in the acquisition of neurologic reflexes during 
postnatal days only in males. No major differences in the acquisition of maturity were observed between 
littermate controls and neudesin-null mice in the cliff aversion (A, B) and the surface righting tests (C, D). On the 
other hand, neudesin-null male mice reach maturity later than littermate controls in the air righting, postural reflex 
and negative geotaxis tests (E, G, I); the same was not observed in females (F, H, J).  
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Mouse behavior is multimodal, quantifying it is only possible when the same animal is exposed to 
multiple behavioral tests covering a wide range of behaviors over several days (Crawley and 
Paylor, 1997). We performed a z-normalization (Guilloux et al., 2011) that allowed us to group 
tests of the same behavioral dimension using z-scores. Grouping all vestibular dependent reflexes 
tested in a single vestibular score showed a significant difference between neudesin-null male 
mice and respective controls (p<0.05); neudesin-null mice had higher vestibular z-score (Nenf-/-= 
0,39±0,13 vs Nenf+/+=-0,15±0,09) (fig.3A) which reflects that in the absence of NENF animals 
reach vestibular maturity later. This difference was not observed between genotype when 
strength related tests were evaluated together using the z-score (figure 3B). 
 
Figure 3 - Influence of neudesin ablation (Nenf-/-) in the acquisition of neurodevelopmental milestones 
in male mice. Z-score translates the power of the sum of 5 tests for vestibular maturation (A) and the power of the 
sum of 2 tests for strength maturation (B). *p<0.05 
 
Nenf ablation disrupts monoaminergic neurotransmission  
Taking into account the sex differences above described, with an increased sensitivity in male 
mice in the absence of neudesin in vestibular area dependent tests, together with the anxious-like 
phenotype observed only in adult male neudesin-null mice (Novais et al., 2013), we next 
searched at the neurochemical level for alterations that may support the mild delay described in 
vestibular dependent tasks during post natal development in males. We performed HPLC to 
quantify monoamines in brain regions (vestibular area, brain stem, cerebellum and motor cortex) 
involved in acquisition of neurological milestones of neudesin-null males at PND21; relevant 
findings are represented in figure 4. The brain stem was the brain region analyzed that displayed 
the major alterations in monoaminergic neurotransmission. In this region, neudesin-null animals 
showed significantly more 5HT (figure 4A) when compared to littermate controls 
(Nenf+/+=1,36±0,31 vs Nenf-/-= 2,63±0,25) (p<0,001); this was translated in a significant 50% 
decrease of the 5HIAA/5HT ratio in neudesin-null mice (p<0,05) (figure 4C). A similar increase in 
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the levels of NE (Nenf+/+=0,85±0,13 vs Nenf-/-= 1,25±0,10) (p<0,05) was also observed in the 
brainstem. NE was also decreased in 21% in the motor cortex of neudesin-null mice (p<0,05) 
(figure 2B). In the cerebellum neudesin-null mice displayed a 42% decrease in serotonergic 
activity, reflected by the ratio of 5HIAA/5HT, as well as a 60% decrease, when compared to 
control littermates, in dopaminergic activity reflected by the ratio HVA/DA (p<0,05) (figure 2D). 
Another finding was the 60% decrease in dopaminergic activity in the vestibular area of neudesin-
null mice revealed by the ratio HVA/DA in 60% (p<0,05) (figure 2E). No significant differences 
were found for the other neurotransmission parameters analyzed in the remaining brain regions. 
 
 
Figure 4 - Monoaminergic neurotransmission in brain region of neudesin-null (Nenf-/-) and respective 
control littermate (Nenf+/+) mice at 21 days of age. Quantification of monoamines levels (µg/g of tissue) in 
the brain stem (A) and motor cortex (B) brain regions. Monoaminergic activity is presented as the 
neurotratransmitter/respective metabolite ratio in the brain stem (C) cerebellum (D) and vestibular area (E). NE- 
noradrenaline, DA- dopamine, 5HT- serotonin, DOPAC- 3,4 dihydroxyphenylacetate, HVA- homovanillic acid and 
5HIAA- 5-Hydroxy-indole-acetic acid. Values are mean±SEM. *p<0,05, **p<0.001. 
 
Discussion 
Given the altricial nature of rodents, the early postnatal period is an informative time window to 
study the maturation process of neural systems. In fact, the three first postnatal weeks are a 
critical time window for correct neurodevelopment in rodents. For instance, it has been reported 
that both mild and severe stressors during this time period have irreversible consequences in the 
adult brain function (Mesquita et al., 2006;Mesquita et al., 2007). Nenf is expressed in the 
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developing brain (Kimura et al., 2006), but no studies addressed its importance in the brain 
maturation process from birth until adulthood. Here we studied, for the first time, the postnatal 
development of a mouse strain with the constitutive ablation of the Nenf gene. We performed a 
developmental milestone analysis that evaluates the acquisition of postnatal neurological reflexes 
and found it is mildly delayed in neudesin-null mice. Most interestingly, this delay in postnatal 
development was sex-specific, since it was only observed in males. To discard possible 
confounding effects, we used neudesin-null and littermate controls reared by heterozygous dams. 
Neudesin heterozygous female mice do not present reduced fertility and raise normal litters; 
mother-litter contact was observed everyday during the milestones examination.  
In the somatic development, neudesin-null mice showed a sex-specific difference in weight; 
males weight being significantly less than females weight from PND19 to PND21. Nevertheless 
this difference did not interfere in the delay observed in vestibular maturation in neudesin-null 
mice, since the time window in which animals achieve maturity in these tests ranges from PND9 
to PND14. Most importantly this weight difference is transient since adult neudesin-null males do 
not show weight differences (Novais et al., 2013). Contradictorily it has been reported that 
intracerebroventricular delivery of recombinant NENF has an anorexic effect in adult mice, 
reducing food intake and body weight and this was observed to be regulated by BDNF signaling 
(Byerly et al., 2013). On the other hand, NENF was shown to modulate adipogenesis in vitro 
(Kimura et al., 2009), thus it is possible that NENF is transiently relevant in adipose tissue 
maturation during development, at least in males.  
Postnatal changes are associated to progressive maturation of sensory and motor skills, which 
are closely associated with the vestibular system (Khan et al., 2004). Regarding vestibular 
dependent tests, we could observe gender-specific retardation in reaching maturity in the air 
righting and negative geotaxis tests, with only males displaying the delay. In the postural reflex 
test both genders (only significant in males) showed a delay in maturation, while no delay was 
observed in motor development (walking test); this evidence might suggest a compensatory 
mechanism by brain regions involved in motor functions for the vestibular impairment. The 
adequate postural control is essential for the acquisition of motor and strength of fine 
movements, which occurs later in development (Geisler and Gramsbergen, 1998). Thus, this 
delay in the postural and body awareness dependent of the vestibular system, with no difference 
between genotypes in motor skills acquisition, suggests a region and/or time window specificity 
of NENF influence, but only in males.  
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Neurotrophic support is important for the correct development of the CNS; namely it participates 
in the correct formation of functional afferent connections between brain regions. For instance, 
neurotrophic factors are known to modulate monoaminergic activity in the brain (Mamounas et 
al., 1995;Juric et al., 2006) and neurotrophins delivery to specific brain regions was correlated 
with altered monoaminenergic activity (Altar et al., 1994). To further dissect the molecular 
alterations responsible for the developmental delay observed in postural and body righting 
mechanisms, we have evaluated the monoaminergic profile of neudesin-null mice. Regions 
chosen for this analysis were the ones closely involved in movement output: brain stem, 
cerebellum, motor cortex and vestibular area in which monoamines have been described to 
participate in the maturation of spinal reflexes (Anden et al., 1964;Herregodts et al., 1990). We 
observed a very significant difference in 5HT in the brain stem and consequent defective 
serotonergic turnover, as well as a higher turnover in the cerebellum. Serotonin is produced in 
the raphe nuclei from where it projects to form the serotoninergic neural system. Descending 
serotonergic projections to spinal cord achieve maturation around PND10 concomitant with 
motor activity maturation (Ballion et al., 2002). Neudesin-null mice did not show impairment in 
the ontogeny of motor activity, suggesting preserved serotonergic descending projections. 
Importantly, neurotrophic factors, such as BDNF, are known to be upregulated in response to 
several types of neuronal disturbance during the postanatal period (Scheepens et al., 2003) and 
this upregulation was correlated with serotonergic terminal loss and neurochemical content 
alteration in regions such as the brain stem (Koprich et al., 2003). Norepinephrine is mainly 
produced at the locus coeruleus of the brain stem and establishes adult innervation in the first 2 
postnatal weeks of age. It is known that spinal descendent projections play an important role in 
reflex control (Coradazzi et al., 2010). In this study we observed a significant increase in NE in 
the brain stem in the absence of NENF. On the other hand, NE was found to be decreased at the 
motor cortex, which suggests that both descending and ascending NE projections (Waterhouse et 
al., 1983) can be compromised in neudesin-null mice. The increased quantity of NE and 5HT in 
the cellular bodies of the brain stem might suggest that these neurotransmitters are not being 
effectively synthetized and/or trafficked to the synaptic cleft. Of notice, it was shown that BDNF 
could increase 5HT synthesis in raphe neurons by increasing expression of tryptophan 
hydroxylase (Eaton et al., 1995). Interestingly NENF can upregulate BDNF levels, at least in the 
hypothalamus (Byerly et al., 2013). It is possible that a compensatory mechanism (BDNF) might 
arise in the absence of an important player, in this case neudesin, during development. 
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Nevertheless, this compensation might still not correct the absence of neudesin and thus 
become an incorrect adaptation. It is tempting to hypothesize that the mechanism by which 
NENF might influence 5HT levels in the brain stem at PND21 involves, directly or indirectly, 
BDNF action.  
The dopaminergic system matures later in juvenile life, after the third week (Herlenius and 
Lagercrantz, 2004) and thus the low levels of dopamine we detected are related to immature 
dopaminergic inputs. Nevertheless in the absence of NENF, dopaminergic activity, especially at 
the vestibular area and the cerebellum, is decreased. Whether the genotype differences in the 
levels of dopamine are related to the behavioral phenotype observed is uncertain but possible 
since treatment with dopamine agents ameliorates vestibular compensation (Petrosini and 
Dell'Anna, 1993). 
The most striking finding in the neurodevelopment of neudesin-null mice is the gender-specific 
difference observed in vestibular dependent tests. Different sex steroids participate in brain 
postnatal development processes, particularly in the cerebellum (Dean and McCarthy, 2008). For 
instance, it is known that during early neonatal development, estrogen and progesterone, as well 
as their neurosteroid precursors play a role in cerebellar dendritic sprouting, spinogenesis and 
synaptogenesis (Tsutsui, 2012). Also, it was shown that estrogen modulates tryptophan 
hydroxylase expression in raphe neurons (Clark et al., 2012). As described previously, NENF is a 
heme/steroid binding protein (Kimura et al., 2008). Although binding to steroids, both in vitro 
and in vivo, is still to be proven, physiologically the interaction between NENF and sex steroids 
can be of relevance for this gender difference observed. In particular, it was recently proposed 
that NENF has a role in the non genomic actions of progesterone in the CNS (Singh et al., 2013).  
The mechanism by which NENF absence results in the postnatal developmental and 
neurochemical differences observed is yet to be determined and should next be addressed. 
Furthermore, we should next explore how this delay and differences in neurochemical content 
observed in neudesin-null male pups impacts adult life and is related with the behavioral 
phenotype observed in adult neudesin-null (Novais et al., 2013). 
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Abstract 
Neudesin, also known as neuron derived neurotrophic factor (NENF), is a heme/steroid binding 
protein. In vitro it has been shown to be a potent stimulator of embryonic neuronal precursors 
proliferation and differentiation, as well as a survival factor for neurons. Surprisingly, in vivo 
neudesin’s putative neurotrophic action is unknown. In this study, we have used neudesin-null 
mice and performed a global characterization of the proliferation state of the adult neurogenic 
niches of male and female neudesin-null animals. We have found a decrease in the hippocampal 
subgranular zone (SGZ) of the dentate gyrus proliferation in neudesin-null mice but only in males. 
We further assessed neurogenesis taking into consideration the dorsal-ventral axis of the 
hippocampus and found that neudesin-null males have less proliferating neuroblasts in the 
ventral division but not in the dorsal division of the hippocampus. Nevertheless, this difference in 
the number of proliferating neuroblasts at the ventral division of the hippocampus did not 
translate into a functional difference evaluated by the amount of glutamate released. Additionally, 
we have performed neurospheres cultures of adult subventricular zone (aSVZ) and SGZ of 
neudesin-null mice and observed that the clonal expansion capacity of neurospheres isolated 
from the SGZ, but not from the aSVZ, of neudesin-null mice is lower when compared to controls. 
All together, this study represents the first in vivo confirmation for the neurotrophic capacity of 
neudesin at the neurogenic niches, particularly the SGZ of the hippocampus.  
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Introduction 
Neuron derived neurotrophic factor (NENF), commonly known as neudesin, is a secreted 
neuronal protein with 21 KDa and 171 aminoacids (Kimura et al., 2005;Bath and Lee, 2010). 
Since neudesin presents a cytochrome b5-like heme/steroid binding domain in it’s primary 
structure, it is classified as a member of the membrane associated progesterone receptor family 
(MAPR) (Cahill, 2007;Kimura et al., 2008). While neudesin is highly expressed in neurons at 
embryonic stages in the brain and spinal cord, in adult mice neudesin is also expressed in other 
organs besides the nervous system, namely in the heart, lung and kidneys, among others 
(Kimura et al., 2005). In the central nervous system (CNS), neurons differentiate between E13.5 
and E16.5, while glia appears later in development; interestingly, neudesin is expressed in all of 
these embryonic stages (Kimura et al., 2006). Of notice, in the embryonic brain, during the 
cortical formation neudesin is highly expressed but this expression is restricted to the pre-plate 
region, where post-mitotic neurons are located; hence, it was not found in regions of precursors 
proliferation and migration (Kimura et al., 2006). The specific pattern of neudesin expression and 
secretion by neurons suggests that it plays a role exclusively over neurons and not other neural 
cell types. In fact, in vitro, neudesin was shown to promote proliferation and differentiation of 
neural precursors into a neuronal lineage as well as to promote the survival of mature neurons 
(Kimura et al., 2005;Kimura et al., 2006). Given these properties elicited by recombinant 
neudesin in vitro and the pathways activated by neudesin, this protein was proposed to be a 
neurotrophic factor (Kimura et al., 2005).  
While extensive in vitro evidence exists for a potential neurotrophic action of neudesin in the 
proliferation and differentiation of embryonic neural precursor cells (NPCs), no studies have 
addressed neudesin action on adult NPCs. In the adult brain there are two main neurogenic 
niches, the subventricular zone (aSVZ) of the lateral ventricles of the brain and the subgranular 
zone (SGZ) of the dentate gyrus (DG) of the hippocampus (Seaberg and van der Kooy, 2002). 
Although both have different patterns of differentiation and regulation, they share similar 
embryonic cellular ancestors and stages of differentiation (Zhao et al., 2008). aSVZ neurogenesis 
mainly feeds the olfactory bulbs, since neuroblats migrate from the aSVZ through the rostral 
migratory stream until they reach the olfactory bulb, where some differentiate and integrate the 
olfactory neurocircuitry (Tramontin et al., 2003). In the SGZ, neuroblats migrate to the granular 
zone of the DG, where they differentiate into young granular neurons that project to the CA3 
region and integrate the hippocampal circuitry (Piatti et al., 2011). For both neurogenic niches, 
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several neurotrophic factors play different roles in all of the above-described stages (Lee and Son, 
2009;Bath and Lee, 2010).  
As described, neudesin ability to promote proliferation, differentiation and survival were 
demonstrated in vitro in embryonic neural precursors and early post-natal neurons. Whether 
neudesin neurotrophic potential also participates in the modulation of adult neurogenesis and in 
vivo is unknown. In this study we assess the role of neudesin in the regulation of the two adult 
neurogenic niches, the aSVZ and the SGZ, taking advantage of mice with a target deletion of the 
neudesin gene.  
 
Methods 
Animals 
A mouse strain with targeted deletion of the neudesin gene, provided by Merck-Serono under a 
material transfer agreement, was used. The neudesin-null (Nenf-/-) mouse strain was generated by 
using a 129/SvEv genomic library from a BAC clone and the target construct was made by 
deletion of the entire coding sequence of the neudesin gene (exons 1 to 4, approximately 12KB) 
and replacing it by a LacZ-neomicin cassette. The target DNA was then inserted into embryonic 
stem cells (FiH4 ES cells), where the homologous pieces of DNA were recombined. The cells 
identified as homologous recombinant clones were microinjected into C57BL/6F1 blastocysts to 
generate chimeric mouse. Initial genotyping was performed using a loss-of-native-allele assay. 
Animals used in this study were backcrossed to a C57BL/6F background.  
Littermate controls (Nenf+/+) and neudesin-null (Nenf-/-) animals were obtained by crossing 
heterozygous animals. Mice genotype was confirmed by PCR using two independent sets of 
primers: one for the LacZ cassette, specific for the Nenf-/- genotype: LacZ-foward 5’-
GGTAAACTGGCTCGGATTAGGG-3’ and LacZ-reverse 5’-TTGACTGTAGCGGCTGATGTTG-3’; and 
another for the Nenf gene, specific for Nenf+/+ animals: Nenf-intron3 5’- 
CTTGGAGTTTGGGGCTGATA-3’, Nenf-exon4 5’-TGGCTTTGTACACCTTGCTG-3’. The amplified 
fragments were of 210bp and 176bp, respectively, and distinguishable by electrophoresis 
through a 1,5% agarose gel. Confirmation of loss of neudesin synthesis in Nenf-/- was also 
obtained by performing immunohistochemistry with a neudesin-specific antibody (Sigma, Aldrich, 
St. Louis, USA) in brain samples of both control and neudesin-null mice; neuronal expression of 
neudesin was not detected in neudesin-null mice. 
Animals were maintained under 12 h light/dark cycles at 22±1ºC, 55% humidity and fed with 
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regular rodent’s chow and tap water ad libitum. This study was approved by the Portuguese 
national authority for animal experimentation, Direcção Geral de Veterinária (permission ID: 
DGV9457). All experiments were performed in accordance with the guidelines for the care and 
handling of laboratory animals, as described in the Directive 2010/63/EU of the European 
Parliament and of the Council. 
 
Administration of 5-bromo-2’-deoxyuridine (BrdU) for proliferation assessment 
BrdU is a thymidine analogue that is incorporated in DNA during the S phase of the mitotic cycle. 
BrdU is often used to label proliferative cells in the brain. To detect proliferating cells, BrdU 
(Sigma Aldrich) (50mg/Kg) was delivered intraperitoneally (i.p.) 24h prior to sacrifice.  
 
Immunohistochemistry 
Animals were transcardially perfused, under anesthesia [ketamine hydrochloride (150 mg/Kg) 
with medetomidine (0.3 mg/Kg)], with 4% of paraformaldehyde (PFA) in phosphate-buffered 
saline (PBS). After perfusion, brains were removed from the skull, left 1h in 4% PFA solution, 12h 
in 30% sucrose solution and then embedded in O.C.T. compound and snap-frozen in liquid 
nitrogen. Immunohistochemistry was performed on coronal sections (20 μm) with an anti-BrdU 
primary antibody at a dilution of 1:50 (Mouse Anti-Bromodeoxyurine, Clone Bu20a, DAKO, 
Spain). This was then detected using Ultravision Detection System (Lab Vision, Freemont, CA, 
USA), and the reaction developed with 3,3’-diaminobenzidine substrate (Sigma Aldrich). Sections 
were subsequently counterstained with 25% hematoxylin diluted solution. For this analysis 8-week 
old littermate controls and neudesin-null mice (n=7 in each group) of each gender were used.  
Immunofluorescence analysis was performed in the same conditions as the 
immunohistochemistry, the primary antibodies used were: doublecortin (DCX) (rabbit polyclonal, 
Abcam, UK) at a dilution of 1:500 and BrdU (rat anti-BrdU, BU1/75 clone, Abcam) at a dilution 
of 1:100. Fluorescent secondary antibodies (Invitrogen, Carlsbad, CA, USA), anti-rabbit and anti-
rat, respectively, were used to detect the primary antibodies at a dilution of 1:1000. To label the 
nucleus, incubation with 4',6-diamidino-2-phenylindole (DAPI; Sigma Aldrich) at a dilution of 
1:1000 was performed. Antibodies were diluted in PBS-0.5% Tween/10% FBS and incubated 
overnight at 4ºC, for the primary antibodies, and 2 hours at room temperature, for the secondary 
antibodies. For the immunofluorescence analysis, we used 6 neudesin-null and 6 littermate 
control male animals with 8 weeks of age.  
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Stereology 
The number of BrdU positive cells was assessed in the neurogenic niches (aSVZ and SGZ) using 
an Olympus BX51 microscope (Olympus, Hamburg, Germany) associated to the Visiopharm 
Integrator system (VIS) software (version 2.12.3.0). Coronal sections comprised aSVZ between 
bregma 0.86 mm and 0.14 mm and SGZ -1.22 mm to -2.30 mm coordinates (Paxinos G., 
2001). The number of BrdU positive cells was normalized for the area (mm2).  
 
Confocal imaging and quantitative analysis 
To assess the number of proliferating neuroblasts (DCX+/BrdU+) at the SGZ, the hippocampus 
was separated in 2 divisions: dorsal and ventral hippocampus; the dorsal hippocampus ranged 
from coordinates -1.22 mm to -2.30 mm and the ventral from -3.40 mm to -3.80 coordinates 
(Paxinos G., 2001). Six animals per genotype (Nenf+/+ and Nenf-/-) were assessed and 3 sections 
from each animal were analyzed for both hemispheres. BrdU positive cells were identified using a 
confocal microscope (FV1000; Olympus) and the total number of double DCX+/BrdU+ positive 
cells was counted. The number of DCX+/BrdU+ was normalized for each SGZ area analyzed using 
a BX51 Olympus microscope attached to a camera with the StereoInvestigator software (MBF 
Bioscience, Vermont, USA). 
 
Glutamate quantification 
The levels of glutamate were measured using high performance liquid chromatography, 
combined with electrochemical detection (HPLC/EC). 
Neudesin-null male mice were sacrificed by decapitation (Nenf+/+=10 and Nenf-/-=8). Skulls were 
rapidly snap frozen in liquid nitrogen to avoid degradation during macro dissection. Brains were 
carefully dissected for dorsal and ventral hippocampus on ice with the help of a 2X magnifying 
lens (SZX7, Olympus), following a stereotaxic brain atlas (Paxinos G., 2001). Dissected tissues 
were weighed and then homogenized and deproteinized in 100 μL of 0.2 N perchloric acid 
solution (Applichem, Darmstadt, Germany) containing 7.9 mM Na2S2O5 and 1.3 mM Na2EDTA 
(Riedel-de Haën AG, Seelze, Germany), centrifuged at 15,000 r.p.m. for 45 min at 4 °C and the 
supernatant was stored at −80 °C until analysis. Glutamate levels were measure in a reverse 
phase ion-pair chromatography with precolumn derivatization on a Pharmacia-LKB 2248 high-
performance liquid chromatography (HPLC) pump coupled with a BAS LC4B electrochemical 
detector, as previously described (Kokras et al., 2009) 
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Neurospheres assay 
Hippocampi and aSVZ from 3-6 days old Nenf+/+ and Nenfmice were dissected carefully and 
meninges and choroid plexus were removed. Tissue was triturated in DMEM F12 (Gibco, 
Rockville, MD, USA) with 10% Fetal Bovine Serum (FBS) with the help of a P1000 pipette; upon 
completion of tissue dissociation, cell suspension was centrifuged at 900 r.p.m. and supernatant 
carefully discarded. Single cells were plated in DMEM F12 media supplemented with GlutaMAX 
(Gibco), 100 U/ml penicillin, 100 μg/ml streptomycin (Gibco), 1% B27 (Gibco), 10 ng/ml 
epidermal growth factor (Gibco), and 10 ng/ml basic fibroblast growth factor (Gibco). 
Neurospheres were allowed to form and grow for 5 days. Splitting of neurospheres was 
performed using 0.05% of trypsin in DMEM F12 and mechanical dissociation with a P1000 
pipette followed by incubation for 3 minutes at 37ºC; trypsin was then inactivated with 10% FBS, 
cells centrifuged at 1000 r.p.m. and supernatant discarded. Single cells were counted using a 
Neubauer chamber and 1 cell/μL was plated in the same media with growth factors in 48 well 
plates, 6 wells per each condition for the clonal density assay. 10 cells/μl were plated in DMEM 
F12 with 10% FBS for the differentiation assay in 24 well poly-D-lysine coverslips for 5 days, 3 
wells per each condition.  
 
Immunocytochemistry 
To assess in which cell type the neurospheres differentiate, we analysed the number of 
astrocytes using immunocytochemistry technique. For that, cells were fixated for 20 minutes in 
4% PFA and blocked in 0.4% FBS diluted in PBS at room temperature for 1 hour. A glial fibrillary 
acidic protein (GFAP) antibody (polyclonal rabbit anti-GFAP, DAKO) at a dilution of 1:200 was 
incubated at room temperture for 1 hour. Fluorescent secondary antibody (Invitrogen), anti-rabbit 
at a dilution of 1:1000 was used to detect primary antibody. To label the nucleus, incubation with 
DAPI (Sigma Aldrich) at a dilution of 1:1000 was performed. Primary and secondary antibodies 
were diluted in PBS and all washes were performed with PBS as well.  
 
Statistical analysis 
All values presented are expressed as the mean ± SEM and significance was verified by using the 
Mann-Whitney test for independent samples. Differences were considered significant when 
p<0.05. 
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Results 
The absence of neudesin impairs proliferation in the SGZ of males but not females 
In this work, we aimed at evaluating, in vivo and in vitro, the effect of neudesin ablation in the 
adult neurogenic niches. We initially injected the DNA thymidine-analog BrdU 24h before 
sacrifice, which mainly labels fast dividing cells.  
We found that proliferation occurring in the SGZ in the absence of neudesin (Nenf-/- mice) was 
significantly reduced by approximately 50% when compared to littermate controls (Nenf+/+) in both 
brain hemispheres (figure 1A). Most interestingly, this difference is gender specific since no 
differences were observed between mouse strains in the SGZ proliferation of females (figure 1B).  
 Figure 1 - Characterization of the proliferation profile of the SGZ and aSVZ neurogenic niches of 
neudesin-null mice. BrdU labeling shows significantly less BrdU positive cells in the sub-granular zone (SGZ) of the 
dentate gyrus of male neudesin-null (Nenf-/-) animals when compared to control littermates (Nenf+/+) (A). On the other 
hand similar numbers of mitotic cells incorporating BrdU are observed in the adult subventricular zone (aSVZ) of 
male Nenf+/+ and Nenf-/- mice (C). In female mice proliferation at both the SGZ (B) and the aSVZ (D) does not differ 
between genotypes. Data is presented as mean ± SEM. *p<0.05. LH= left hemisphere and RH= right emisphere. 
 
When total cell proliferation was analyzed in the other adult neurogenic niche, the aSVZ, no 
differences were observed between neudesin-null and littermate control mice, in both males and 
females (Figures 1C and 1D). 
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Abnormal proliferation in the SGZ of neudesin-null male mice is restricted to the 
ventral dentate gyrus 
The diminished proliferation observed in the SGZ of neudesin-null male mice prompted us to 
further characterize neurogenesis in this neurogenic niche. We labeled proliferative neuroblasts 
by using both DCX and BrdU immunostaining (BrdU+DCX+) throughout the dorsal/ventral axis of 
the DG. While no differences were observed between mouse strains in dorsal SGZ proliferating 
neuroblasts (Figure 2A), neudesin-null mice ventral SGZ displayed significantly less BrdU+DCX+ 
cells in both right (60% decrease) and left (70% decrease) hemispheres when compared to 
control littermates, (p<0.05) (Figure 2B).  
Although no differences were observed in the proliferation in the aSVZ, we analyzed the number 
of proliferating neuroblasts in this niche taking in consideration the topographic specificities of 
this region (Falcao et al., 2012). Nevertheless, we failed to observe any differences between 
control and neudesin-null mice in the density of BrdU+DCX+ cells in any of the divisions (anterior, 
intermediate, posterior) or regions (rostral migratory stream, dorsal, dorsolateral, ventral) of the 
aSVZ (data not shown).  
 
Figure 2 - Proliferating neuroblasts at the dorso-ventral axis of the subgranular zone (SGZ) of the 
dentate gyrus (DG) of neudesin-null mice. The density of proliferating neuroblasts (BrdU+DCX+) in the dorsal 
SGZ (A) in neudesin-null (Nenf-/-) males is similar to littermate controls (Nenf+/+), but a marked decrease is observed 
in the ventral SGZ (B) of neudesin-null mice in both right and left hemispheres (RH and LH, respectively). Data is 
presented as mean ± SEM. *p<0.05.  
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Altered pattern of proliferation in the dorsal-ventral axis of the DG does not reflect 
in the glutamatergic quantity 
The ventral axis specific sharp decrease in proliferative neuroblasts observed in the adult 
hippocampal DG of neudesin-null mice prompted us to evaluate if this would be translated 
functionally. Since proliferating neuroblasts in the SGZ give rise to glutamatergic granule neurons 
that integrate into the granule cell layer we quantified glutamate in both the dorsal and the 
ventral hippocampus of neudesin-null adult males and respective littermate controls. No 
differences between genotypes were observed in the dorsal division of the hippocampus (Nenf+/+ 
=6801 ± 1264 vs Nenf-/-=5247 ± 1103) (Figure 3A). Despite a marked decrease in the levels of 
glutamate in the ventral hippocampus (Nenf+/+ =2489 ± 561 vs Nenf-/-=1203 ± 255) (Figure 3B), it 
did not reach statistical significance. 
 
 
Figure 3 – Quantification of glutamate in the dorsal and ventral division of the hippocampus of 
neudesin-null mice. Control (Nenf+/+) and neudesin-null (Nenf-/-) mice show similar levels of glutamate at the dorsal 
(A) and ventral (B) hippocampus. Data is presented as mean ± SEM. 
 
Neurospheres forming capacity of DG neural stem cells is diminished in neudesin-
null mice 
Dentate gyrus derived and aSVZ neural stem cells from pups were cultured in vitro and formed 
neurospheres, and clonal expansion capacity was assessed. Neural stem cells isolated from 
neudesin-null mice hippocampi formed significantly less neurospheres when compared to 
controls (p<0.05) (Figure 4A) while no difference was observed in the clonal expansion of 
neurospheres isolated from the aSVZ (Figure 4B). After 5 days in culture we have split the 
hippocampal neurospheres, plated single cells and allowed it to grow in culture for 5 days in 
astrocytic differentiation conditions. Then, after performing GFAP immunocytochemistry, we 
evaluated differentiation into astrocytes from both neudesin-null and control littermate mice. We 
dorsal hippocampus
Nenf+/+ Nenf-/-
0
2000
4000
6000
8000
10000
G
lu
ta
m
at
e 
(n
g/
g 
ti
ss
ue
)
ventral hippocampus
Nenf+/+ Nenf-/-
0
1000
2000
3000
4000
G
lu
ta
m
at
e 
(n
g/
g 
ti
ss
ue
)
A B
 85 
observed that neural stem cells from controls under these culture conditions form 75%, while 
neudesin-null mice derived neural stem cells form 50% of astrocytes when compared to 
control(Figure 4C).  
 
Figure 4 - Neurosphere forming and differentiation assays. Neural stem cells isolated from postnatal 
hippocampi of neudesin-null (Nenf-/-) form significantly less neurospheres than those isolated from control (Nenf+/+) 
mice (A). No differences were observed when analyzing neural stem cells isolated from postnatal aSVZ (B). Nenf-/- 
neural stem cells differentiate less into astrocytes (GFAP+) than Nenf+/+ (C). Data is presented as mean ± SEM. 
*p<0.05.  
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Discussion 
This study is the first to show in vivo the initially described in vitro neurotrophic properties of 
neudesin. We have demonstrated this by analyzing the effects of NENF ablation in the adult mice 
neurogenic niches, the SGZ and the aSVZ, of mice. We show that neudesin-null male mice do not 
display differences in the proliferation in the aSVZ when compared to control littermates, but in 
the SGZ the absence of neudesin leads to decreased cell proliferation. Surprisingly, this 
difference is sex specific, since neudesin-null females do not show abnormal proliferation in both 
neurogenic niches, when compared to control animals. Since only males revealed a decrease in 
SGZ proliferation, we have further characterized neurogenesis throughout the dorsal-ventral axis 
of the SGZ in neudesin-null mice, and revealed a significant decrease in neurogenesis exclusively 
in the ventral division of the SGZ. Furthermore, in vitro we show that neural stem cells isolated 
from the hippocampus of neudesin-null mice form less neurospheres, and that these adult neural 
stem cells display an altered pattern of differentiation, at least in the astrocytic lineage. These 
findings support an additional role for neudesin as a neurotrophic player in the adult brain. 
It was previously demonstrated that recombinant neudesin has potent neurotrophic capacity, as 
demonstrated in vitro in cultures of embryonic neural precursor cells and neurons (Kimura et al., 
2005;Kimura et al., 2006). Noteworthy not much was known about such neudesin properties in 
vivo and particularly in adulthood. Both aSVZ and SGZ neural stem cells embryonically have 
origin in radial glia from germinative layers of the telencephalon (Tramontin et al., 2003) and are 
comprised of three similar main cell types: stem cells, progenitor cells and neuroblasts (Ming and 
Song, 2011). Specifically, in the aSVZ the quiescent cells are slow dividing radial glia stem cells 
(type B), which give rise to type C cells, also known as transient amplifying progenitors (TAP’s), 
that in turn differentiate into type A cells (also designated neuroblasts). In turn, in the SGZ, 
proliferating radial glia stem cells and nonradial precursors (type I and II) give rise to intermediate 
progenitor cells that will differentiate into neuroblasts (Zhao et al., 2006). TAP’s, intermediate 
progenitors and neuroblasts are fast dividing cells, and are easily labeled by short pulses of 
BrdU, the thymidine analogue. Although the cell population of these niches, aSVZ and SGZ, is 
very similar, they are regulated in distinctive ways. For instance, it is known that sex hormones 
(Tanapat et al., 1999) and chronic anti-depressant treatment (Malberg et al., 2000) have 
modulatory effects in hippocampal neurogenesis but not in aSVZ neurogenesis. Here we show 
that neudesin plays a different role in this two neurogenic niches: at the aSVZ it does not seem to 
be essential for the maintenance of neural precursor cells whereas in the SGZ the absence of 
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neudesin yields a significant decrease in cell proliferation.  
Considering the differentiation process of neural stem cells, the transition from transient 
amplifying progenitors into neuroblasts is a critical period in the niche maintenance and in the 
neurogenesis process; it is a selective period closely regulated by intrinsic and extrinsic factors 
(Sierra et al., 2010). Importantly, we observed that neudesin might play a crucial role in this 
stage of neurogenesis, given the observed decrease in proliferating neuroblasts, at least in the 
ventral part of the SGZ. Of notice, we demonstrated previously that adult neudesin-null male mice 
have an anxious like behavior as well as impoverished dendritic branching of granular neurons of 
the ventral DG (Novais et al., 2013), but whether the decreased population of proliferative 
neuroblasts is related to the anxious-like phenotype is yet to be determined.  
Newly formed neurons migrate to the granular zone of the DG and project an axon to the CA3 
layer of the hippocampus, thus integrating into the hippocampal circuitry (Zhao et al., 2008;Piatti 
et al., 2011), which mainly is composed of glutamatergic neurons. This newly born granular cell 
integration in the circuitry is highly modulated by neurotrophins and particularly BDNF 
(Lessmann, 1998;Lu, 2003)). BDNF not only regulates glutamatergic synaptic transmission (Lu, 
2003) but also regulates proliferation in this region (Sairanen et al., 2005). Of note, functionally, 
while the absence of neudesin decreased neurogenesis in the ventral DG, it does not seem to 
interfere in glutamatergic neurotransmission in the hippocampus, in both dorsal and ventral 
division. This indicates that neudesin, contrarily to what is known for BDNF, seems to participate 
only in the regulation of the neurogenic process rather than influencing the integration of 
newborn neurons into hippocampus circuits. Complementary studies with newly born neurons 
survival and integration into the hippocampal circuitry of neudesin-null mice should be performed 
to verify this hypothesis.  
Neural stem cells have been extensively characterized for their in vitro phenotype and behavior 
(Richards et al., 1992;Barkho et al., 2006;Pastrana et al., 2011) and provide a powerful tool to 
better understand proliferation and differentiation profiles. We observed that neural stem cells 
isolated from neudesin-null mice hippocampi form less neurospheres, when compared to 
controls, in the clonal expansion assay. Interestingly this difference was only observed in the 
clonal expansion assay with hippocampal precursors and not with aSVZ neurospheres. This 
reinforces the selective role for neudesin as a putative modulator of the hippocampal neurogenic 
niche. When SGZ neural precursors were cultured in astrocytic differentiation conditions, a 
decrease in astrocyte differentiation was observed in the absence of neudesin. Interestingly, 
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recombinant neudesin in vitro was shown to differentiate precursor cells exclusively into neurons, 
as well as having selective modulation over neurons and not astrocytes (Kimura et al., 2005). In 
contrast, we show that, at least in astrocytic differentiation conditions, adult neudesin-null mice 
precursor cells differentiate into astrocytes, which suggests that physiological levels of neudesin 
are also important in the astrocytic lineage differentiation.  
Steroid hormones and altered physiological states such as stress, pregnancy and lactation, have 
important effects on hippocampal neurogenesis (Tanapat et al., 1999;Galea et al., 2013). In fact, 
during the estrous cycle, the estrogen peak correlates with high proliferative rates in the 
hippocampus (Pawluski et al., 2009;Velazquez-Zamora et al., 2012). Moreover it was shown that 
the sex steroid progesterone regulates proliferation of neural stem cells (Liu et al., 2009). Despite 
being a member of the MAPR family, binding of steroids to the steroid-binding domain of 
neudesin was not shown to be necessary for its neurotrophic activity, at least in vitro (Kimura et 
al., 2008). Importantly, although still a matter of debate across mammalian species, the SGZ is 
distinctively regulated in males and females (Lagace et al., 2007). Noteworthy, neudesin-null 
male mice show less hippocampal proliferation when compared to littermate controls but the 
same genotype effect was not observed in females; this observation might point for a role for 
neudesin in sex steroids action at least in the SGZ niche, which should next be explored.  
Herein, we provide the first characterization of the adult neurogenic niches (aSVZ and SGZ) of 
neudesin-null mice. We show that neudesin’s regulation of embryonic neurons and its precursors 
reported previously (Kimura et al., 2006) is dissimilar from the observed in the modulation of the 
adult niches. Furthermore we observe a selective effect in the hippocampus in the absence of 
neudesin, specifically an impairment in neural progenitor cells proliferation and differentiation is 
only observed in the ventral DG; interestingly these observations correlate with the atrophy of 
granular cells previously described in the ventral hippocampus of adult neudesin-null mice 
(Novais et al., 2013). We suggest that neudesin plays a role in the maintenance of ventral 
hippocampus neurogenesis and this might be related to granular cells plasticity and the 
increased anxiety state of male neudesin-null mice.  
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Discussion and future perspectives 
Since neudesin (NENF) was first described, just 8 years ago (Kimura et al., 2005), as being a 
putative novel neurotrophic factor, it has not received much attention. In this period, studies were 
confined to two research groups that performed different approaches studying the function of 
NENF by using recombinant protein delivery strategies in vitro and in vivo (Kimura et al., 
2005;Kimura et al., 2008;Byerly et al., 2013). In total 10 manuscripts were published (based in 
a PubMed search for the terms "neudesin" or any of the other designations attributed to this 
protein as indicated previously in the introduction section) in which NENF is referred. In this 
sense the lack of a neudesin-null mouse strain precluded further advances in the understanding 
of NENF physiological relevance. In this work we performed an extensive characterization of the 
impact of NENF ablation in the CNS. Specifically we evaluated the: 
I) Impact of NENF ablation on adult behavior; 
II) Postnatal neurodevelopment of neudesin-null mice; 
III)  Modulation of adult neurogenic niches by NENF. 
Each of these topics and its interconnectivity will next be discussed in an attempt to provide 
further insight into the nature of NENF and its relevance in CNS function. 
 
Many constitutive knockout mouse models for neurotrophins and/or their receptors die 
prematurely at the first stages of postnatal development (Snider, 1994). Of note, constitutive 
NENF ablation in rodents, the model used in this study, did not result in premature death and 
neudesin-null mice seem as healthy as littermate controls. This observation indicates that the 
potential role of NENF as a neurotrophic factor is certainly not as determinant for global body 
physiology as many of the classical neurotrophic factors.  
It is known that NENF is broadly expressed in the adult brain (Kimura et al., 2005). The extensive 
expression profile of the neurotrophins family in the brain, is in accordance with its relevance in 
the correct maintenance of the CNS (Huang and Reichardt, 2001). In this sense, and although it 
has not yet been performed, a broad ontogenic neudesin expression characterization is of 
interest to better understand if spatial and temporal variations in the NENF expression pattern 
are determinant for region specific brain function. This is even more relevant given the behavioral 
phenotypes of neudesin-null mice described previously (Chapters 3 and 4). Despite the lack of 
this knowledge it is certain that NENF is only secreted by neurons (Kimura et al., 2005) and, 
although a possible membrane receptor was not found, it is known that its neurotrophic ability is 
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neuron specific (Kimura et al., 2005). Furthermore while NENF is expressed in neurons 
throughout the whole brain, apparently there are specific brain regions where neurons are more 
vulnerable to NENF’s absence than others. Particularly, in this study we have observed that the 
amBNST and the ventral DG neurons have impoverished dendritic arborization in the absence of 
NENF (chapter 3). These alterations in cytoarchitecture were concomitant with the adult anxiety 
behavior phenotype observed in neudesin-null mice. The main brain regions involved in the 
anxiety process modulation are the ventral hippocampus, the amygdala and the BNST. The 
anxiety like behavior observed in neudesin-null males was in novel contextual paradigms such as 
the EPM, the LDB and the NSF. These are considered tests for state anxiety that rely on cortical 
processing, involving the hippocampus and the prefrontal cortex (Adhikari et al., 2010). 
Surprisingly neudesin-null mice did not present an anxious profile in the AS test. This test is 
based on a reflex response to an aversive stimulus that tests for a different dimension of anxiety, 
a more generalized and innate response (trait anxiety) highly dependent on the amygdala-BNST 
communication (Walker and Davis, 2008). In fact the ventral hippocampus might be the key 
structure in the behavioral phenotype observed in neudesin-null mice. Indeed, the ventral 
hippocampus appears to be involved in state anxiety processing that involves alterations in the 
HPA axis control providing negative feedback (Herman et al., 1995). The anteromedial division of 
the BNST (amBNST) receives projections mainly from the central and medial amygdala (CeA, 
MeA) and in turn projects to the PVN; the amBNST is the principal division of the BNST involved 
in the neuroendocrine regulation during stress response (Dong et al., 2001). This could explain 
that the decrease dendritic length observed in the amBNST of neudesin-null male animals does 
not translate in an impaired PVN activation, as it was not observed any other stress related 
alteration, like mood or cognition on neudesin-null animals. Given the alterations observed in the 
ventral hippocampus DG granular neurons and the amBNST neurons it would be interesting to 
evaluate if the stress response in neudesin-null mice is impaired upon stress exposure (such as 
chronic unpredictable stress). 
Besides neurotrophic factors, there are many other molecular players that take place in the 
modulation of anxiety behavior. Examples of those players are neurosteroids, which are 
synthetized from cholesterol and/or steroids in the periphery and the CNS. Allopregnanolone, a 
progesterone metabolite, is one of the most common active steroids in the brain. These 
compounds act as allosteric modulators of neurotransmitter receptors, such as GABAAR, NMDA 
and sigma receptors, acting as potent sedatives, anesthetics, anxiolytic or even anti-depressant 
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molecules (Reddy, 2010). Progesterone alone and its metabolites (allopregnanolone) also 
functions as a neurosteroid with anesthetics effect through the non-genomic activation of 
membrane PR (Korneyev and Costa, 1996;Reddy and Apanites, 2005). Regarding anxiety 
modulation, neurosteroids have revealed to be potent players. The GABAergic system is an 
important neurotransmitter system in the regulation of anxiety and actually anxiolytics, as 
benzodiazepines, are GABA receptors agonists. NENF is a member of the membrane associated 
progesterone receptor (MAPR) family, and although NENF binding to progesterone was not yet 
demonstrated, it was proposed to be a player in progesterone non-genomic actions (Kimura et 
al., 2013). Given the anxious-like phenotype of neudesin-null mice and since progesterone and its 
metabolites play a role in anxiety, it would be interesting to analyze the levels of progesterone 
and its precursors, such as allopregnanolone as well as the activity of the respective 5α 
reductase metabolizing enzyme, in brain regions involved in anxiety processing in neudesin-null 
mice. Most importantly, the fact that in neudesin-null mice only males appear to be susceptible 
to the hyper-anxious state further prompts for the analysis of these steroid metabolites.  
 
 
As described previously, NENF’s main cellular effect is the ability to induce embryonic neuron 
differentiation and survival in culture (Kimura et al., 2006). Here we studied the adult neurogenic 
niches of neudesin-null mice to evaluate if the absence of NENF resulted in impairment in 
proliferation and differentiation in the neurogenic niches. In this work we show that neudesin-null 
males display less proliferating neuroblasts at the ventral division of the hippocampus (chapter 
5), which might translate into decreased integration of new neurons in the hippocampal circuitry. 
Furthermore we observed that, in the adult brain NENF modulates differently the adult SVZ and 
the SGZ neurogenic niches. Even further interesting, the absence of NENF results in a differential 
modulation of the neural stem cell niche at the dorsal and ventral DG axis. Also in this case, the 
ventral hippocampus revealed to be the most vulnerable structure to the absence of NENF. 
Importantly in disorders such as depression and anxiety (Evans et al., 2012;Sah et al., 2012) 
neurogenesis was also observed to be decreased, although the contribution of neurogenesis 
occurring at the dorsal or ventral division of the SGZ to these disorders is still a matter of debate 
(Banasr et al., 2006;Eadie et al., 2009;Lacefield et al., 2012;O'Leary et al., 2012). Nonetheless 
since dorso-ventral divisions of the hippocampus are functionally different neurogenesis occurring 
in each of these divisions has been implicated differentially: dorsal hippocampal neurogenesis in 
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cognition and ventral hippocampal neurogenesis in mood disorders (Kheirbek and Hen, 2011). 
Whether the decrease in ventral hippocampal neurogenesis is involved in the anxious-like 
phenotype observed in neudesin-null mice should next be studied in further detail. Namely how 
neudesin modulates neurogenesis and by rescuing neudesin’s expression it reverts the observed 
effects in the DG and in the anxiety phenotype observed in neudesin-null mice.  
The mismatch between neudesin-null males and females in the neural cell proliferation pattern at 
the hippocampal SGZ is another striking finding. Neudesin-null males have less cell proliferation 
in this neurogenic niche than their respective littermate controls, while in females this difference 
is not observed. Several intrinsic and extrinsic factors that modulate the neurogenic niche might 
explain gender differences, including life experiences, sexual hormones, pregnancy and lactation 
(Galea et al., 2013). As indicated above in the absence of NENF, males display less neural cell 
proliferation at the ventral division of the hippocampus and they present an anxious like behavior. 
Both findings were not observed in female neudesin-null mice. These observations were made in 
adult neudesin-null females nulliparous not synchronized for the estrous cycle. Given the fact that 
NENF was suggested to play a role in progesterone non-genomic actions (Kimura et al., 2013) it 
would be interesting to study if NENF absence affects neurogenesis and neuron morphology of 
the hippocampus, during different phases of the female adult life such as adolescence, 
pregnancy and post partum. It would then be possible to correlate NENF’s function with different 
levels of sex hormones in particular progesterone. On the other hand, it would be interesting to 
study if chronic treatment with progesterone, reverts the differences observed in neudesin-null 
males 
 
 
Neurotransmitters are key players in the modulation of complex behaviors and disruption in any 
neurotransmitter system balance can culminate in mild to severe behavior impairments. Anxiety 
behavior is also characterized by an imbalance in neurotransmission. In agreement, treatment 
with selective serotonin reuptake inhibiters (SSRIs) and norepinephrine reuptake inhibitors 
(SNRIs) were shown to have positive results in treating patients with generalized anxiety disorder 
(De Salas-Cansado et al., 2012) reinforcing a role for monoamines in this condition. The 
monoamine dopamine (DA) is a relevant modulator of the mesolimbic and mesocortical systems, 
which have been implicated in the regulation of mood (Diehl and Gershon, 1992). Interestingly 
parkinsonian patients exhibit anxiety states as social phobia (Stein et al., 2002). In this work we 
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show that neudesin-null mice have less DA reaching the ventral hippocampus, which was 
translated into a higher DA turnover ratio of HVA/DA. Previous studies have shown the 
differential contribution of dopamine D1 and D2 receptors for anxiety, suggesting a closer 
involvement of D1 activation in an anxiolytic effect (Rodgers et al., 1994). Importantly the ventral 
part of the hippocampus shows higher D1 expression, specifically in the DG granular neurons 
dendrites (Mansour et al., 1992). Neudesin-null mice present an atrophy of DG granular neurons. 
It is possible that the lack of neurotrophic support at the ventral hippocampal DG leads to a 
downregulation of D1 and hence impaired dopaminergic activity. On the other hand, it is known 
that DA modulates synaptic plasticity in this brain region (Hamilton et al., 2010), and thus 
diminished DA input might indirectly influence DG neurons morphology in neudesin-null mice.  
The anxiety response mechanism is highly modulated by several different and complementary 
systems, making it hard to decipher the crucial elements for its regulation because of its 
heterogeneous nature. Levels of circulating neurotrophins, for instance BDNF, were shown to be 
altered in patients with impaired anxious response (Suliman et al., 2013). Furthermore a 
polymorphism in the human BDNF gene was correlated with a susceptibility to develop anxiety 
and depression (Montag et al., 2010;Li et al., 2013). The neurotrophic support provided to 
specific populations of neurons influences correct synapse formation and neurotransmission 
(Cohen-Cory, 2002). NENF is expressed in tyrosine hydroxylase (TH) neurons, particularly at the 
substantia nigra and the ventral tegmental area (VTA) (or own observation). It is possible that 
NENF is providing trophic support and thus is modulating DA afferent projections. On the other, 
hand the absence of NENF during development might result in subtle and specific alterations in 
dopaminergic circuitry formation. Another relevant fact, is that a GABAergic system dysregulation 
has been implicated in impaired DA release, pointing in a crosslink between anxiety and DA 
(Diehl and Gershon, 1992). Moreover, neurosteroids are known to modulate GABAAR, and 
expression levels of the rate-limiting enzyme 5α reductase depends on dopaminergic system 
during stress paradigms (Bortolato et al., 2011). Some authors have shown a strong crosstalk 
between progesterone signaling and the dopaminergic system, with DA and some DA analogues 
being able to activate the progesterone nuclear receptor (PR) and hence influence gene 
expression (Foreman and Moss, 1979;Mani et al., 1994;Mani et al., 2009). It is not know if a 
similar cross-talk exists in what concerns the non-genomic actions of progesterone to which 
NENF is thought to be involved (Kimura et al., 2013).  
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As indicated above, many factors contribute to the development of an anxious-like state. The 
spatial (circuits involved) and the temporal (time window imprinting) interplay of the factors that 
elicit an anxiety state is also relevant. Here we observed that the absence of NENF manifests in 
an anxious like phenotype only when animals are exposed to novel environment paradigms. 
Although this phenotype is observed in adult males, the developmental contribution cannot be 
forsaken. The mouse model used in this work is a constitutive knockout model, which implies 
that from gestation homozygous knockout animals do not synthetize neudesin. Thus the CNS has 
to rearrange in order to deal with the absence of the protein during the apparent normal 
development of animals. Whether the impairments observed are due to i) the system response to 
deal with the absence of a relevant protein, or ii) the direct absence of the protein in the time 
point of analysis, are two questions that cannot be answered using this mouse model. We will 
next focus on the first aspect, in order to comprehend if neurodevelopment could have a possible 
contribution for the adult anxious phenotype observed.  
Undeniably, in psychiatric disorders, the effect of genetic and environmental factors may 
converge on molecular pathways and brain circuits related to neurotrophic factors functioning. 
For instance it is known that the neurotrophic factor FGF2 has crucial role in brain development 
and that in the absence of it animals develop hyperactivity, as well as increased anxiety behavior 
(Terwisscha van Scheltinga et al., 2013). On the other hand it is known that early postnatal 
stress, such as maternal separation, leads to an adult anxious phenotype (Mesquita et al., 2007) 
and decreased BDNF expression in the hippocampal formation (Roceri et al., 2002). We studied 
if the absence of NENF influences behavior by affecting postnatal neurodevelopment. For that we 
have evaluated the postnatal acquisition of neurodevelopment reflexes in neudesin-null animals. 
We have observed that only neudesin-null males show a mild impairment in the acquisition of 
vestibular dependent neurological reflexes when compared to littermate controls. This was 
accompanied by altered monoaminergic activity in brain regions involved in the vestibular reflex 
maturation. These differences are transitory since all animals achieve maturity, which points for 
an adaptive time window of maturation that involves the adjustment of the system to the absence 
of NENF. Again, only neudesin-null males presented this delay in maturation, a further evidence 
reinforcing a possible sex-specific role for neudesin. The gender variance in neudesin-null mice 
calls our attention to the potential NENF action in progesterone activity (Kimura et al., 2013). 
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Nuclear PRs are more expressed in the developing (from E18 until PND10) male than female 
brain (Wagner, 2008), but after this period sex differences in the PR expression were not studied. 
PR is also transiently expressed in the posnatal dentate gyrus of the hippocampus, motor, 
sensory and reticular core nuclei (from P1 until P14) and in specific dopaminergic neuronal 
populations (Quadros et al., 2008). Although the perinatal ovary does not produce progesterone 
until the second week of life, high levels of progesterone are detectable in breast milk, and de 
novo synthesis of progesterone occurs in the male and female brain (Ingram et al., 
1999;Micevych and Sinchak, 2008); this prompts for an important involvement of progesterone 
in brain development. NENF has 30% homology to the membrane progesterone receptor 
PGRMC1 (Kimura et al., 2012) and is thought to participate in progesterone non-genomic 
signaling (Kimura et al., 2013) but no evidence exists for its participation in progesterone 
genomic (PR dependent) actions. PGRMC1 is highly expressed and needed in the cerebellar 
cortex postnatal development (Sakamoto et al., 2008). We found that, the cerebellum of 
neudesin-null males shows a decrease in the activity of the serotonergic and dopaminergic 
systems. If the mild latency in neurologic reflexes acquisition presented by neudesin-null males 
depends more in the trophic action or in the progesterone signaling of NENF is yet to be 
deciphered. Furthermore, with the present evidence it is not possible to discriminate if this 
impairment contributes to the anxious like phenotype observed in adult neudesin-null males.  
 
 
With the work developed in this thesis we demonstrate that neudesin is relevant for normal CNS 
functioning. Furthermore by pinpointing several novel roles for neudesin in the brain, we have 
elicited novel challenges that deserve further clarification. For instance, finding a link between the 
sex-specific modulatory actions of neudesin in the adult hippocampal neurogenic process and the 
anxiety-like behavior is certainly relevant and should next be studied.  
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